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INTRODUCTION 
Leg weakness in growing turkeys has become a problem of increasing 
economic importance to poultry producers. Leg problems in turkeys are 
known to arise from inadequate nutrition, genetics, disease and poor 
management conditions. While many of the individual factors that result 
in the leg problem syndrome are known, the problem has not yet been 
eliminated. 
Vitamin A and ascorbic acid, two vitamins which are known to influence 
the formation of connective tissue and bone, have not been previously 
studied in connection with turkey bone development. Vitamin A influences 
the development of bones by its effect on the cellular activity and 
function of bone cells. Vitamin A deficiency increases the activity of 
periosteal osteoblasts, thus resulting in the over-growth of bony tissues. 
Excess vitamin A inhibits osteoblastic activity and has no effect on the 
activity of osteoclastic cells, thus a thinning and rarification of bone 
result. Therefore, bone cell activity is dependent on the vitamin A 
status of the animal and changes in the vitamin status upset the normal 
process of bone remodeling. 
Ascorbic acid is required for the normal production of collagen 
molecules and is needed to maintain cells of connective tissue in a 
physiological condition. Ascorbic acid has also been implicated as 
having an effect on calcium metabolism in chickens. Egg shell thickness 
seems to be improved by ascorbic acid supplementation while serum 
calcium is reduced. 
In order to investigate the effects of vitamin A and ascorbic acid 
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on poult growth and bone development, four experiments were conducted. 
Dietary vitamin A levels were chosen to be in a range as might be found 
in practical poultry rations. Diets were formulated using natural feed 
ingredients so that results would be applicable to the normal production 
of turkeys. 
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REVIEW OF LITERATURE 
Vitamin A and Growth Performance 
Extensive research has been conducted to ascertain the optimal dietary 
levels of vitamin A for practical poultry diets. The criteria for vitamin 
A adequacy have been based on a wide variety of biological responses. 
Depending on the biological processes involved, they can be grouped into 
(a) growth response; (b) measurement of vitamin A levels in vivo, such as 
liver storage and plasma levels; (c) reproductive performances such as rate 
of egg production, percent fertility and percent hatchability; and (d) 
other miscellaneous responses. 
Dietary recommendations for poultry, based on the vitamin supplements 
available prior to the introduction of stabilized vitamin A, overestimated 
the dietary requirements (Henshaw and Lloyd, 1934; Wilgus, 1940; Wharton 
et al., 1949). Chemical estimates of provitamin A in natural plant sources 
also measure carotene isomers of lower relative biological potency (Beeson, 
1965) and conversion of beta-carotene to vitamin A is species-dependent. 
Olsen et al. (1959) reviewed the literature on vitamin A stability in 
poultry diets and pointed out that vitamin A supplements would deteriorate 
in mixed diets. 
The 1971 National Research Council (NRC) vitamin A requirements for 
turkeys appear to be based on three research reports dealing directly with 
turkeys and on numerous reports dealing with the vitamin A requirements of 
CÎi—clcsTiQ. 
Gurcay et al. (1950) studied the utilization of crystalline carotene 
and vitamin A acetate by turkey poults. Utilization of vitamin A sources 
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was determined by body weight and vitamin A levels of liver and plasma. 
Maximal body weights were noted for 8-week-old poults receiving 4400 lU 
vitamin A acetate per kilogram of diet or diets containing 8000 or more 
lU of carotene. Supplementation of vitamin A acetate at levels of 8000, 
17600, 35200 or 70400 lU/kg reduced final body weights. Storage of vitamin 
A in the liver increased with the increasing levels of vitamin A acetate 
above 4400 lU, but increasing levels of dietary carotene did not increase 
liver storage of vitamin A. 
Couch et (1971) reported that 2670 to 4721 lU vitamin A per 
kilogram of diet is needed to meet the dietary requirements of turkey 
poults. Their milo-soy diets were calculated to contain either 0, 1100, 
2200, 4400, 6600 or 8800 lU/kg. The best overall body weights at 8 and 
12 weeks of age were obtained on diets containing 4400 to 6600 lU/kg. A 
marginal vitamin A deficiency was noted at 8 to 12 weeks of age for diets 
containing 1100 or 2200 lU/kg as was manifested by lighter body weights. 
A significant weight reduction at 12 weeks was noted for the diet contain­
ing 8800 lU, thus indicating a possible toxicity of vitamin A. 
The vitamin A requirement for turkey breeder hens has been stated as 
4000 lU/kg of diet by the 1971 NRC report. Data of Stoewsand and Scott 
(1961) indicate 2650 lU is adequate to maintain egg production and hatch-
ability when vitamin A palmitate is used as the vitamin A source. However, 
higher dietary levels were needed to maintain high levels of vitamin A in 
the egg and for carry-over to poults. Poults from hens receiving 2650 
TTl/kj £rpw nn-rmally nn aHpoiiafp (UptB. hut growth was restricted in poults 
given marginal levels of the vitamin. Stoewsand and Scott (1961) reported 
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that 1760 lU/kg was an adequate level of vitamin A for normal growth In 
poults. 
Jensen (1965) reported on turkey breeder hens supplemented with 
either 880, 2200, 2640 or 3280 lU of vitamin A palmltate per kilogram of 
diet. A reduction in egg production was noted in hens supplemented with 
880 or 2200 lU, while maximal production was obtained with hens receiving 
either 2640 or 3280 lU vitamin A. The rate of egg production of hens 
that had been receiving either 880 or 2200 lU/kg was increased by feeding 
the diets containing 3280 lU of vitamin A. 
The ability of turkeys to utilize beta-carotene has recently been 
questioned by Creger et al. (1971a). A solution of beta-carotene was 
administered orally and the change in liver and plasma vitamin A levels 
were used as the criteria for conversion of carotene to vitamin A. Non­
significant changes in liver and plasma vitamin A were noted, thus Creger 
et al. (1971a) concluded that turkey poults do not convert beta-carotene 
to vitamin A to any appreciable extent. Creger et al. (1971b) reported 
that dehydrated alfalfa meal calculated to supply 4400, 6600 and 8800 lU 
of vitamin A supported normal growth of turkey poults, but did not Increase 
liver storage of vitamin A. This work is in agreement with the reports of 
Marusich and Bauernfeind (1963) and Flegal et al. (1971) on the utilization 
of carotene by chickens. 
Vitamin A and Bone Development 
The Tnorpholngic effects of vitamin A deficiency on bone development 
have been studied for the past forty years. These effects in young animals 
are present before the rate of growth is retarded and are regarded as a 
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specific consequence of the deprivation. Administration of excess vitamin 
A in young animals produces lesions in endochondral bone formation. 
Ataxia produced in vitamin A-deficient animals results from abnormal 
bone growth that damages the central nervous system (Mellanby, 1950; 
Wolbach, 1954; Barnicot and Datta, 1956; Howell and Thompson, 1967a and b). 
Mellanby (1950) suggested that excessive apposition of periosteal bone in 
vitamin A deficiency restricted the area available for the growing central 
nervous system, thus resulting in nerve damage. Bones other than those 
associated with the nervous system also thickened and coarsened. Mellanby 
(1950) postulated osteoblasts and osteoclasts are altered in position and 
activity, thus the over-growth of bony material. In contrast, Wolbach 
(1954) argued that vitamin A deficiency retarded endochondral bone growth, 
but did not affect appositional growth. 
Barnicot and Datta (1956) attributed the discrepancies between Wolbach 
and Mellanby to age of experimental animals when deficiencies start and to 
the degree of inanition. If vitamin A reserves are exhausted early in the 
rapid growth phase, feed intake is suppressed and cessation of epiphyseal 
growth occurs. The marked effect on epiphyseal growth is not noted in 
maturing animals, thus periosteal abnormalities are more prominent. 
The recent works of Howell and Thompson (1967a and b), Hayes and 
Cousins (1970) and Gallina ^  al. (1970) have reinvestigated the effect of 
vitamin A deficiency on bone development and they support the work of 
Mellanby. Howell and Thompson (1967a) reported on bone development of 
chicks c.t 14, 17, 20, 2^: snd 28 days of vitam-în A deficiency. Differences 
in body weight were not observed until day 17 of deficiency and changes in 
subperiosteal bone were observed after day 20. Adult birds made vitamin 
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Â-de£iclent form periosteal bone lining the vertebral and cranial cavities 
and the marrow cavity of long bones (Howell and Thompson, 1967b). Howell 
and Thompson (1967a and b) concluded that changes in bones of vitamin Â-
deficlent birds are due to an increase in the activity of periosteal osteo­
blasts and that changes in endochondral growth of vitamin A-deficlent chicks 
were due to inanition. Hayes and Cousins (1970) and Gallina et (1970) 
reported that the degree of vitamin A deficiency is critical in the evalua­
tion of bone development in that subtle changes in osteoblastic-osteoclastic 
activity are apparent only when progressive stages or graded levels of 
deficiency are studied. 
Chronic toxicity of vitamin A produces bone lesions in animals. 
Naturally induced hyper-vitamlnosis A frequently occurs in cats and 
Seawright et (1970) have an excellent review on the subject. Rats 
administered retenolc acid develop multiple fractures of long bones due 
to excessive bone reabsorption (Thompson and Pitt, 1960), while chicks do 
not (Baker et al., 1967). Baker et al. (1967) theorized that the bone 
lesion produced by an excess or deficiency of vitamin A results in suppres­
sion or stimulation of osteoblastic activity and boas lesions are produced 
by changes in the natural remodeling process. 
Ascorbic Acid Biosynthesis 
It has been known for some time that chickens do not require exogenous 
ascorbic acid, but Grollman and Lehninger (1957) and Roy and Guha (1958) 
were the first to demonstrAte that kidney tissue is the site cf hiczyzthssls. 
Chaudhuri and Chatterjee (1969) reported that differences in sites of 
ascorbic acid biosynthesis in avian species are correlated with their 
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phylogeny, the more primitive species synthesizing ascorbic acid in the 
kidney and the more developed species synthesizing ascorbic acid in kidney 
and/or liver. Some highly evolved species are unable to synthesize 
ascorbic acid. 
Jacobson and Havens (1971) demonstrated that rooster comb has the 
enzymes needed to synthesize ascorbic acid, but this system is quite 
sensitive to testosterone levels. Hanninen £t (1971) reported that myo-
inositol may be a significant substrate for the production of ascorbic acid 
in hen kidney tissue. 
Ascorbic Acid Supplementation 
While it is generally accepted that ascorbic acid is not a required 
nutrient in poultry diets, there is some suggestion that it may slightly 
improve body weight gains in growing chicks fed purified diets (Briggs 
^ , 1944; Dietrich et al., 1949; Dietrich et ^ ., 1950) and in chicks 
fed natural diets deficient in folic acid (March and Biely, 1953). Data 
presented by Thornton et (1962) possibly indicate that ascorbic acid 
supplementation of purified diets may improve body weight gains in turkey 
poults. 
There are various kinds of evidence that indicate a role for ascorbic 
acid in calcium homeostasis in chickens. Egg shell quality has been 
reported to be improved when ascorbic acid was added to practical laying 
hen diets (Thornton and Moreng, 1958, 1959; Thornton, 1960a and b; El-
Boushy ^  al.. 1968) but the results are inconsistent (Heywang and 
Kemmerer, 1955; Arscott et al., 1962; Hunt and Aitken, 1962; Rumsey, 1969) 
and egg shell may be unaffected. Sullivan and Gehle (1962) reported a 
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nonsignificant decrease in plasma calcium in laying hens supplemented with 
ascorbic acid. 
The role of ascorbic acid in bone formation is generally assumed to be 
limited to its effect on growth and its involvement in the formation of the 
collagen matrix (Vaughan, 1970), but a series of studies at Thornton's 
laboratory indicate that exogenous ascorbic acid influences the movement of 
bone mineral. 
Exogenous ascorbic acid results in the release of calcium from bone 
both vivo and ^  vitro (Thornton, 1968, 1970; Thornton and Omdahl, 1969; 
Ramp and Thornton, 1971) with increase in plasma ascorbic acid phosphatase 
(Thornton and Omdahl, 1969). Ascorbic acid injections of chicks resulted 
in release of bone calcium into the plasma, with the overall effect of 
lowering total plasma calcium (Thornton and Omdahl, 1969). 
Vitamin A by Ascorbic Acid Interaction 
References to an interaction between vitamin A and ascorbic acid are 
noted in the literature. Mayer and Krehl (1948) reported that vitamin A-
deficient rats had lower ascorbic acid tissue reserves and scurvy-like 
symptoms which were curable by ascorbic acid supplementation. Decreases in 
blood plasma ascorbic acid levels were reported to accompany vitamin A 
depletion of calves (Moore and Cotter, 1945) and chicks (Nockels et al.. 
1971). 
Malathi and Ganguly (1964) and Ghosh ^  (1967) have reported 
that activity of L-gulono-y-lactone oxidase is reduced in vitamin A-
deficient rats. Rogers (1969), however, noted that the loss in enzymatic 
activity may be a result of reduced nutrient intake. 
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EXPERIMENTAL 
General Information 
Diets 
Milo-soy starter, grower and finisher diets were formulated to be 
vitamin A-deficient, but to meet or exceed all of the other NRC (1971) 
nutrient requirements (Table 1). Vitamin A and ascorbic acid were added 
to the basal diets to produce experimental diets. 
Table 1. Composition of basal diets deficient in vitamin A 
Ingredient Starter Grower Finisher 
Milo grain 44.2 60.0 75.5 
Soybean meal (49%) 45.0 30.0 15.0 
Fish meal (70%) 4.0 2.5 2.0 
Soybean oil 3.0 3.0 3.0 
Limestone 1.8 1.5 1.5 
Dicalcium phosphate 1.0 2.0 2.0 
Trace mineral mix^ 0.5 0.5 0.5 
Vitamin mix^ 0.5 0.5 0.5 
^race mineral mix provided the following in milligrams per kilogram 
of diet. 
Starter: sodium chloride, 4400; manganese, 136; zinc, 75; iron, 55; 
copper, 9; iodine, 2; cobalt, 0.55. 
Grower and Finisher: sodium chloride, 4500; manganese, 77; zinc, 38; 
iron, 28; copper, 44; iodine, 1.3; cobalt, 0.23. 
^Vitamin mix supplied the following per kilogram of diet: vitamin Dg, 
2250 ICU; vitamin E, 30 lU; vitamin K, 3.5 mg; vitamin B12, 10 meg; 
biotin, 1 mg; folic acid, 2.25 mg; niacin, 175 mg; pyridoxine, 5 mg; 
riboflavin, 9 mg; thiamin, 5 mg; Ca-pantothenate, 40 mg; Santoquin, 175 mg; 
methionine equiv., 1000 mg. 
11 
Laboratory procedures 
Blood Bamplea were taken with a syringe from either the heart or 
brachial vein. Whole blood was transferred to heparinized centrifuge tubes 
and placed in an ice bath until sample collection was completed. Plasma 
was obtained, frozen and stored until chemical analysis could be performed. 
Calcium and magnesium content of blood and femur were determined by 
atomic absorption spectrophotometry using the methods of Perkin-Elmer 
(1968). Plasma inorganic phosphorus and femur phosphorus were determined 
spectrophotometrically using the procedure of Chen et ad. (1956). Total 
plasma ascorbic acid was determined using the spectrophotometer method 
published in the Manual for Nutrition Surveys (1963). 
Poults were sacrificed by cervical dislocation and the left femurs 
were removed. Femurs were cleaned of all adhering muscle and cartilaginous 
caps. Air-dried femurs were extracted with 2:1 chloroform-methanol to 
remove lipid and the fat-free femurs were dried at 105*±2"C. Fat-free 
dry femurs were ashed at 600* to 700°C for eight hours. In Experiment 4, 
fat-free femurs were ground in a Wiley Mill and approximately 200 mg of 
ground bone were used for ash determinations. 
Experiment 1 
Objectives 
Experiments designed to study the Influence of ascorbic acid supple­
mentation of practical poult starter diets have not been reported in the 
literature. However, reports have indicated that ascorbic acid might 
Improve egg shell thickness in heat-stressed laying hens and, therefore, 
might Influence calcium metabolism. The requirement of ascorbic acid for 
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normal development of the collagen matrix of bone is also well-known. 
Thus, the objective of the first experiment was to study the influence 
of exogenous ascorbic acid supplementation in terms of growth, performance 
and calcium metabolism of male turkey poults. 
Experimental design 
Day-old male turkey poults of the Williams strain were obtained from 
the Iowa State University hatchery and fed the basal diet containing 15,000 
lU of vitamin A for a pre-experimental period of six days. Poults were then 
weighed, wing banded and five birds were allotted per pen. Six experimental 
treatments were allotted to 18 pens to make the experiment a randomized 
complete block design. The experiment was conducted for 14 days. 
The basal diet was a milo-soy starter diet (Table 1) which either met 
or exceeded all NRC nutrient requirements, and contained 15,000 lU of 
vitamin A per kilogram. Ascorbic acid was added to the basal diet to give 
dietary levels of 0, 30, 300, 1500 or 3000 p.p.m. A sixth treatment con­
sisted of feeding the diet and giving each poult a daily intraperitoneal 
injection of 0.5 ml of physiological saline solution containing 100 mg of 
L-ascorbic acid. 
Results 
Body weight gains, feed consumption, feed efficiency and a calculated 
total intake of ascorbic acid for the 14-day experimental period in Experi­
ment 1 are shown in Table 2, and the analyses of variance in Table 36, 
Body vjpijht gains of ascorbic acid-injected poults were significantly 
(P<0.01) less than those of either the controls or the dietary supplemented 
birds. Weight gain of the controls tended to be less than that of the four 
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dietary ascorbic acid-supplemented groups, but the difference was not 
significant. Poults supplemented with 3000 p.p.m. dietary ascorbic acid 
significantly (P<0.05) outgalned the controls. 
Table 2. Effect of ascorbic acid (M) supplementation on body weight 
gain, feed consumption and feed efficiency of male turkey 
poults - Experiment 1 
Treatments 
Gain 
(xm) 
Feed 
(Km) 
Feed 
efflciencv 
Total AA 
intake* (mg) 
Control 325 397 1.22 0 
30 ppm 325 457 1.40 14 
300 ppm 341 453 1.33 136 
1500 ppm 334 450 1.35 675 
3000 ppm 348 473 1.36 1420 
Inj ected^ 210 322 1.53 1400 
^Calculated AÀ Intake. 
^100 mg AA dally. 
Feed consumption of ascorbic acid-injected poults was significantly 
(P<0.01) less than that of the controls and dietary ascorbic acid-
supplemented groups. Dietary ascorbic acid-supplemented poults consumed, 
on the average, 60 grams more feed than did controls. Feed efficiency 
of all ascorbic acid-supplemented birds was significantly (P<0.01) poorer 
than that of the controls. Ascorbic acid-injected poults also had a 
significantly (P<0.01) poorer feed efficiency than poults receiving 
dietary ascorbic acid. Total Intake of ascorbic acid of poults fed the 
3000 p.p.m. dietary ascorbic acid level was approximately the same as 
that for Injected poults. 
Plasma ascorbic acid levels are shown in Table 3, and the analyses of 
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Table 3. Effect of ascorbic acid (AA) supplementation on plasma ascorbic 
acid levels - Experiment 1 
Treatments yg AA/ml 
Control 9.6 
30 ppm 10.1 
300 ppm 19.8 
1500 ppm 24.4 
3000 ppm 26.1 
Inj ected^ 11.1 
*100 mg AA daily. 
variance in Table 37. Plasma ascorbic acid levels increased in a linear 
fashion when related to either the log of the dietary ascorbic acid concen­
tration or the log of 1 plus the dietary ascorbic acid concentration (Fig­
ure 1). Ascorbic acid-injected poults had plasma ascorbic acid concentra­
tions which were not significantly different from those of the controls. 
The data for the parameters of bone mineralization are presented in 
Table 4 and the analyses of variance in Table 38. 
Table 4. Effect of ascorbic acid supplementation on femur development of 
male turkey poults - Experiment 1 
Treatments 
Femur 
weight 
(me) 
Femur weight/ 
body weight 
(me/em) 
Femur 
length 
(mm) 
Weight/ 
length 
(me/mm) 
Control 706 1.60 44.6 15.78 
30 ppm 714 1.63 45.5 15.64 
300 ppm 745 1.63 45.4 16.33 
1500 ppm 709 1.59 45.1 15.68 
3000 ppm 730 1.57 45.4 16.05 
Inj ected* 532 1.62 41.5 12.76 
*100 mg AA daily. 
Figure 1. Effect of dietary ascorbic acid on plasma ascorbic 
acid (yg AA/ml) - Experiment 1 
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No significant differences between control poults and dietary ascorbic 
acid-supplemented groups were noted for the weight and length of the femur 
(Table 4), but ascorbic acid-injected birds had significantly (P<0.01) lower 
values than all other treatment groups. The relative femur weight, however, 
was not influenced by any treatment. Weight per length of bone was signifi­
cantly (P<0.01) depressed in ascorbic acid-injected birds. No significant 
differences were noted between control or dietary supplemented birds for any 
of the criteria measured. 
Ash, calcium, phosphorus and magnesium percentages of fat-free dry 
femur, and the ratio of calcium to phosphorus are shown in Table 5 and the 
analyses of variance in Table 39. Ascorbic acid supplementation had no 
effect on these parameters of bone mineralization. 
Table 5. Effect of ascorbic acid supplementation on percent femur ash, 
percent calcium and percent phosphorus - Experiment 1 
Ash Calcium Phosphorus Magnesium 
Treatments (%) (%) (%) Ca/P (%) 
Control 49.09 18.28 8.71 2.101 0.383 
30 ppm 49.59 18.84 8.74 2.157 0.377 
300 ppm 48.91 17.86 8.71 2.052 0.371 
1500 ppm 49.39 17.58 8.61 2.045 0.380 
3000 ppm 49.75 18.54 8.56 2.167 0.383 
Injected^ 49.53 18.06 8.74 2.099 0.404 
100 mg AA daily. 
Plasma calcium, magnesium and inorganic phosphorus were not influenced 
by zT.y treatment as shOT-Tn In Tghle 6. The analyses of variance for plasma 
calcium, magnesium and phosphorus are reported in Table 40. 
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Table 6. Effect of ascorbic acid supplementation plasma calcium, phosphorus 
and magnesium - Experiment 1 
Treatments 
Calcium 
(me/lOO ml) 
Inorganic 
phosphorus 
(me/100 ml) 
Magnesium 
(me/100 ml) 
Control 10.04 5.63 1.683 
30 ppm 10.42 5.87 1.727 
300 ppm 9.90 5.41 1.770 
1500 ppm 10.21 5.27 1.797 
3000 ppm 10.36 5.21 1.737 
Injected^ 10.08 6.05 1.830 
^100 mg AA daily. 
Experiment 2 
Obj actives 
The primary objective of Experiment 2 was to test for possible inter­
actions between vitamin A and ascorbic acid as these vitamins affect growth 
and bone development of growing turkey poults. The secondary objective was 
to obtain more information on the response of turkey poults to mild 
hypo- and hyper-vitaminosis A. 
Experimental design 
The experiment was a 3x4 factorial arrangement of a complete 
randomized block design. Ascorbic acid was supplemented to the vitamin A-
deficient basal starter diet (Table 1) to provide levels of 0, 30, 300 and 
3000 p.p.m. Vitamin A concentrations were 1000, 4000, 16000 lU/kg and will 
be referred to as %NRC. NRfl and 4xNRC. respectively. "NRC" was the 
recommendation for the vitamin A requirement of turkeys as set forth by 
the National Research Council (1971). 
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Day-old male poults of a Broad-breasted White strain were received 
from a commercial hatchery, wing banded and fed the vitamin A-deficlent 
diet for seven days prior to being placed on the 12 experimental diets. 
Three pens, of 10 poults per pen, were fed each of the 12 experimental 
diets. The poults were individually weighed at day seven and unthrifty 
poults removed to improve uniformity among poults. After 14 days on the 
experimental diets, poults were individually weighed and five poults per 
pen were sacrificed for tissue collection. The remaining poults were 
moved to unheated growing batteries and maintained on the experimental 
treatments for an additional 15 days. 
Results 
During the first week of the experiment, one pen of poults developed 
an acute Escherichia coll infection which resulted in mortality and 
retardation of growth. Thus this pen was dropped from the experiment. 
Statistical analysis was conducted with adjustments made for the missing 
data. 
The log of dietary levels of vitamin A and ascorbic acid results in 
equal spacing for the main effects. Thus the subdivision of main effects 
into orthogonal components could be made with resulting response curves 
being on a logarithmic scale. 
Body weight gains for periods 1 and 2 are reported in Table 7 and the 
analyses of variance in Table 41. In period 1, poults fed the ^ NRC and 
4xNRC levels of vitamin A gained more weight than poults on the NRC level 
and this quadratic effect for vitamin A was significant (P<0.05). During 
the second period, poults on the NRC level of vitamin A gained more than 
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did poults fed the WRC and 4xNRC diets, but the effect was not significant. 
Thus the responses to vitamin A concentrations differ between periods 1 and 
2. The overall effects of vitamin A on weight gains for periods 1 and 2 
combined did not indicate treatment differences as the period effects can­
celled each other. 
Table 7. Effects of dietary levels of ascorbic acid and vitamin A on body 
weight gain, feed consumption and feed efficiency - Experiment 2 
Ascor­
bic 
acid 
Period 1 Period 2 
Vitamin L A Vitamin A 
%NRC NRC 4xNRC Av kmc NRC 4xNRC Av 
Body weight gains (gm) 
0 395 383 420 399 768 785 778 777 
30 406 366 409 394 765 769 784 773 
300 411 398 408 406 771 788 752 770 
3000 394 426 421 414 724 783 772 760 
Av 402 393 414 757 781 772 
Feed consumption (gm) 
0 617 603 667 629 1311 1376 1438 1375 
30 583 586 675 615 1360 1328 1361 1350 
300 645 674 643 654 1220 1374 1241 1278 
3000 625 683 682 664 1267 1367 1397 1337 
Av 617 637 667 1289 1361 1359 
Feed efficiency (feed/gain) 
0 1.56 1.58 1.59 1.58 1.71 1.75 1.85 1.77 
30 1.44 1.60 1.65 1.57 1.78 1.73 1.73 1.75 
300 1.57 1.70 1.58 1.62 1.58 1.74 1.65 1.66 
3000 1.59 1.60 1.62 1.60 1.75 1.75 1.81 1.77 
Av 1.54 1.62 1.61 1.71 1.74 1.76 
A&dicion ox chree xevels ox âCxû. nwu ^22.ne 
in either period 1 or 2. In period 1, the 300 and 3000 p.p.m. levels of 
ascorbic acid tended to improve weight gains in poults receiving the NRC 
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levels of vitamin A. The 3000 p.p.m. level of ascorbic acid appeared to 
decrease weight gains of poults fed the ^ NRC level of vitamin A in both 
periods 1 and 2. 
Feed consumption for periods 1 and 2 is found in Table 7 and the 
analyses of variance in Table 41. Increasing the dietary levels of both 
vitamin A and ascorbic acid resulted in a significant linear increase in 
feed consumption in period 1. In period 2, feed consumption was not 
influenced by any dietary treatment. 
The analyses of variance for feed efficiency are presented in Table 
41. In period 1, feed efficiency was significantly (P<0.05) depressed by 
feeding the NRC and 4xNRC levels of vitamin A (Table 7). In period 2, the 
NRC and 4xNRC levels of vitamin A did not significantly depress feed 
efficiency, but the trend was still apparent. Ascorbic acid had no appar­
ent effect on feed efficiency in period 1, but a significant (P<0.05) 
quadratic effect for ascorbic acid was noted in period 2. In period 2, 
the overall effect on feed efficiency of diets with 0 and 3000 p.p.m. 
concentrations of ascorbic acid was essentially the same, while the 30 and 
300 p.p.m. ascorbic acid diets improved feed efficiency compared with feed 
efficiency of poults fed the diets with no ascorbic acid added. 
In period 1, improved body weight gain of poults receiving the 4xNRC 
diets was caused by increased feed intake, but improved weight gains of 
poults fed the %NRC diets resulted from improved feed efficiency. Poults 
fed the NRC diets consumed the most feed in the second period and were 
more efficient than poults fed the 4xNRC diets; thus better weight gains 
were noted. Reduced feed consumption of poults fed %NRC in the second 
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period appears to be responsible for decreased weight gains, but this group 
of poults had the best feed efficiency. 
In period 1, the supplement of 300 and 3000 p.p.m. ascorbic acid 
significantly (P<0.01) increased feed consumption, but it tended to decrease 
feed efficiency. Ascorbic acid effects in the second period were not con­
sistent and trends were not apparent. 
Femur weight and the femur weight/body weight ratio for poults sacri­
ficed at the end of period 2 are reported in Table 8 and the analyses of 
variance in Table 42. The 12 dietary treatments did not differ in their 
effect on femur weights, but the relative femur weights were influenced by 
both vitamin A and ascorbic acid. A significant (P<0.05) cubic effect for 
the dietary ascorbic acid on relative femur weight was noted, but no 
apparent explanation can be offered. The statistical analysis indicates 
that the femur weight/body weight ratio is influenced by a significant 
(P<0.01) quadratic effect produced by the three dietary levels of vitamin 
A. The effect on relative femur weight is questioned because the value 
obtained by calculations for missing data is out of line with other treat­
ments . 
Table 8. Effects of dietary levels of ascorbic acid (AA) and vitamin A on 
femur weight (gm) and the femur weight to body weight ratio (mg/ 
gm) - Experiment 2 
Femur weight Femur weight/body weight 
Ascorbic 
acid 
Vitamin A Vitamin A 
%NRC NRC 4xNRC Av %NRC NRC 4XNRC Av 
0 3.1046 2.9343 3.1166 3.0517 2.39 2.24 2.31 2.31 
30 3.1183 2.9466 3.1430 3.0909 2.41 2.36 2.65 2.48 
300 3.2528 3.0265 3.0023 3.0938 2.4b 2.3Ù 2.57 2.37 
3000 3.0660 3.2139 3.1585 3.1461 2.46 2.36 2.36 2.40 
Av 3.1516 3.0303 3.1051 2.43 2.32 2.42 2.39 
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The ash, calcium, phosphorus and magnesium content, and the calcium/ 
phosphorus ratio of fat-free dry femurs are reported In Table 9 and the 
analyses of variance for these parameters In Table 43. Increasing dietary 
vitamin A resulted In a highly significant (P<0.01) linear decrease in 
percentage femur ash. Increasing levels of ascorbic acid also reduced bone 
mineralization, but this response was nonsignificant. The effect of both 
vitamins on ash components indicates that the response observed may be 
stimulation of matrix formation and not a direct effect on the mechanism 
of bone mineralization. 
Calcification of the femur was decreased in a significantly (F<0.05) 
linear fashion by Increasing vitamin A in the diet. A cubic response of 
ascorbic acid on calcium content of the femur was significant (P<0.01). 
This appears to be due to an Increased bone calcium in poults receiving 
30 p.p.m. ascorbic acid in the and NRC diets. Neither vitamin A nor 
ascorbic acid affected the phosphorus content or the calcium/phosphorus 
ratio of the femur. Magnesium contents of femurs were significantly 
(P<0.01) reduced by diets containing four times the NRC requirement of 
vitamin A. Ascorbic acid did not affect femur magnesium significantly, but 
the higher dietary concentrations tended to depress bone magnesium content. 
Plasma ascorbic acid levels for Experiment 2 are reported in Table 10 
and the analysis of variance in Table 44. Plasma values were measured at 
two and four weeks of the experiment and are designated as periods 1 and 2, 
respectively. Dietary ascorbic acid caused a highly significant (F<0.005) 
Increase In plasma ascorbic acid concentrations. The linear, quadratic 
and cubic responses were all significant, but the linear trend appears to 
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Table 9. Effects of dietary levels of ascorbic acid and vitamin A on femur 
mineralization - Experiment 2 
Ascorbic Vitamin A 
acid %NRC NRC 4xNRC Av 
Ash (%) 
0 45.39 46.07 45.40 45.95 
30 45.75 46.25 44.91 45.64 
300 46.13 45.66 44.81 45.53 
3000 45.79 45.56 44.69 45.35 
Av 46.02 45.89 44.95 
Calcium (%) 
0 15.78 14.78 14.07 14.88 
30 16.25 16.04 14.42 15.58 
300 14.90 14.70 14.07 14.55 
3000 14.78 14.26 14.78 14.60 
Av 15.43 14.95 14.34 
Phosphorus (%) 
0 8.50 7.95 8.17 8.21 
30 7.89 8.44 7.62 7.98 
300 8.18 7.96 7.64 7.93 
3000 7.92 8.26 7.93 8.03 
Av 8.12 8.15 7.84 
Calcium/phosphorus ratio 
0 1.858 1.859 1.728 1.815 
30 2.081 1.902 1.902 1.962 
300 1.835 1.848 1.847 1.843 
3000 1.867 1.735 1.836 1.824 
Av 1.910 1.836 1.836 
Magnesium (%) 
0 0.411 0.409 0.387 0.402 
30 0.412 0.426 0.383 0.407 
300 0.400 0.396 0.399 0.399 
3000 0.406 0.401 0.375 0.394 
Av 0.407 0.408 0.386 
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Table 10. Plasma ascorbic acid levels (yg/ml) - Experiment 2 
Ascorbic 
acid 
Vitamin A Period 
%NRC NRC 4xNRC Av 1 2 
0 8.86 9.43 9.80 9.37 9.78 8.95 
30 10.27 10.70 11.95 10.98 11.27 10.69 
300 18.48 19.21 17.23 18.31 18.13 18.47 
3000 27.45 24.42 23.95 25.27 24.81 25.73 
Av 16.27 15.94 15.74 
Period 1 16. 63 15.82 15.54 16.00 
2 15.90 16.05 15.93 15.96 
to best fit the data (Figure 2). This response corresponded to the log of 
the dietary levels of ascorbic acid. A highly significant (P<0.01) 
interaction between the linear effect of both vitamin A and ascorbic acid 
was noted. The ^ NRC levels of vitamin A caused the lowest plasma ascorbic 
acid levels at the 0 and 30 p.p.m. dietary ascorbic acid levels, but the 
highest plasma ascorbic acid values in poults fed the 3000 p.p.m. diets. 
Conversely, the highest ascorbic acid plasma concentrations at 0 and 30 
p.p.m. dietary ascorbic acid were noted for the 4xNRC vitamin A diets, 
but were lowest at the 300 and 3000 p.p.m. levels of ascorbic acid supple­
mentation. No differences were noted between periods 1 and 2. 
Plasma calcium values, in mg/100 ml of plasma, are reported in Table 
11 and the analysis of variance in Table 45. Plasma calcium was not 
influenced by any dietary treatment. A highly significant (P<0.005) 
difference was noted between periods 1 and 2. The mean for period 1 was 
11.75 me% and 10.19 mg% in period 2. 
Figure 2. Effects of dietary vitamin A and ascorbic acid on 
plasma ascorbic acid - Experiment 2 
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Table 11. Plasma calcium levels (mg/100 ml) - Experiment 2 
Ascorbic Vitamin A Period 
acid %NRC NRC 4xNRC Av 1 2 
0 10.96 10.43 10.87 10.76 11.75 9.75 
30 11.06 11.49 10.99 11.18 11.95 10.40 
300 11.54 10.80 10.93 11.09 12.02 10.16 
3000 11.20 10.71 10.66 10.85 11.27 10.43 
Av 11.18 10.85 10.87 
Period 1 11.90 11.72 11.63 11.75 
2 10.47 9.99 10.09 10.19 
Analysis of variance for plasma magnesium is reported in Table 46 and 
the plasma magnesium data in Table 12. Magnesium concentrations in plasma 
were shown to be influenced by the different dietary vitamin A treatments. 
Linear and quadratic effects of vitamin A were statistically significant at 
(P<0.01) . The two-factor interactions, ascorbic acid linear x vitamin A 
linear and ascorbic acid linear x vitamin A quadratic, were both signifi­
cant (P<0.05). The reduction in plasma magnesium from 2.049 mg% in period 
1 to 1.698 mg% in period 2 is highly significant (P<0.005). 
Table 12. Plasma magnesium levels (mg/100 ml) - Experiment 2 
Ascorbic Vitamin A Period 
acid %NRC NRC 4xNRC Av 1 2 
0 1.916 1.693 1.980 1.863 2.040 1.686 
30 1.915 1.889 1.922 1.909 2.071 1.747 
300 2.001 1.786 1.894 1.877 2.121 1.633 
3000 1.936 1.904 1.694 1.845 1.962 1.727 
Av 1.941 1.818 1.860 
Period 1 2.163 1.999 1.983 2.049 
2 1.720 1.637 1.737 1.698 
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Plasma Inorganic phosphorus Is presented In Table 13 and the statisti­
cal analysis is shown in Table 45. Inorganic phosphorus was not influenced 
by either vitamin, but the 1 mg% drop between period 1 and period 2 was 
highly significant (P<0.005). 
Table 13. Plasma inorganic phosphorus (mg/100 ml) - Experiment 2 
Ascorbic 
acid 
Vitamin A Period 
%NRC NRC 4xNRC Av 1 2 
0 5.55 5.93 5.93 5.81 6.34 5.27 
30 5.92 5.63 5.32 5.62 6.17 5.07 
300 5.71 5.76 5.37 5.62 6.11 5.12 
3000 6.11 6.32 5.21 5.88 6.28 5.48 
Av 5.83 5.91 5.46 
Period 1 6.45 6.27 5.95 6.23 
2 5.20 5.55 4.97 5.23 
Experiment 3 
Objectives 
The effects of supplemental ascorbic acid were not consistent between 
the first two experiments; thus a third experiment was conducted. In 
order to gain more information on the effects of ascorbic acid, and to detect 
possible ascorbic acid x vitamin A interactions, an experiment was designed 
in which poults were fed diets supplemented with 3000 p.p.m. ascorbic acid 
for two weeks, and were then fed diets without ascorbic acid. It was 
theorized that 3000 p.p.m. dietary ascorbic acid would suppress endogenous 
synthesis of the vitamin, and that on its removal from the diet, a temporary 
nypovitaminosis would result. Such rapid changes in the ascorbic acid 
status of poults were postulated to provide new insights into the role of 
ascorbic acid on growth and bone development. 
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Experimental design 
Experiment 3 consisted of a 3x2 factorial arrangement of treatments in 
a randomized block design with vitamin A supplementation of the basal diet 
(Table 1) at either 1000, 4000 or 16000 lU/kg and ascorbic acid added at 
either 0 or 3000 p.p.m. The vitamin A diets are referred to as the ^ NRC, 
NRC and 4xNRC diets. The experiment was conducted using week-old male 
poults of a white strain that had been fed the vitamin A-deficient diet from 
the time of hatching. This experiment was conducted for four weeks and 
poults were sacrificed at weekly intervals for bone analysis. Three poults 
from each pen were sacrificed in the weeks of period 1, while only two 
poults were sacrificed in the weeks of period 2. 
Each of the six dietary treatments was randomly assigned to a pen of 
13 poults in each of four batteries. Each battery contained all six of the 
individual treatments and was therefore considered as a block. After two 
weeks of the experiment, the dietary ascorbic acid was "crossed-over" in 
two of the blocks; that is, ascorbic acid was removed from diets of poults 
that had been supplemented in period I and it was added to the diets of 
poults that had not been previously supplemented. No changes were made in 
the vitamin A levels when the ascorbic acid was crossed-over. 
For statistical analysis, the poults were differentiated by groups. 
Group 1 contained the poults given the same treatments for the four weeks 
of the experiment, while group 2 contained the two blocks in which the 
ascorbic acid cross-over took place. The experiment was further broken 
down into the periods of two weeks each for statistical analysis. 
Results 
Body weight gains, feed consumption and feed efficiency data for both 
group 1 and 2 were summarized to demonstrate the vitamin A effects (Table 
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14) on these parameters since the main effects of ascorbic acid were non­
significant. The analysis of variance for body weight gain, feed consump­
tion and feed efficiency is reported in Tables 47, 48 and 49, respectively. 
Table 14. Effect of vitamin A on body weight gain, feed consumption and 
feed efficiency - Experiment 3 
Dietary 
vitamin A 
Period 1 Period 2 
Av 
Weeks ' on experiment 
1 2 3 4 
Body weight gain (gm) 
a^NRC 130 217 295 368 252 
NRC 134 220 301 391 261 
4xNRC 126 214 277 369 247 
Av 130 217 291 376 
Feed consumption (gm) 
%NRC 184 341 481 706 428 
NRC 192 372 516 709 447 
4xNRC 182 332 511 723 437 
Av 186 348 502 712 
Feed efficiency (feed/gain) 
%NRC 1.42 1.54 1.63 1.92 1.63 
NRC 1.44 1.68 1.72 1.82 1.66 
4xNRC 1.44 1.60 1.85 1.97 1.71 
Av 1.43 1.61 1.73 1.90 
Combined body weight gains for both groups were influenced by vitamin 
A in a quadratic manner. In group 1, vitamin A effects were nonsignificant, 
although a strong quadratic trend was noted. The linear vitamin A effect 
was significant (P<0.05) in group 2. In Table 14, a quadratic effect of 
vitamin A is noted in each week of the experiment. The effect is the 
result of birds fed the NRC diet outgaining the poults on the higher- and 
lower-vitamin A diets. The effect of the reduced gain of poults fed the 
%NRC diets during the first week would be expected since birds were depleted 
of vitamin A during the seven-day pre-experimental period, and a marginal 
deficiency would be produced. A reasonable explanation for the reduction of 
weight gains in poults fed the 4xNRC level of vitamin A in the first two 
weeks cannot be offered because the time appears to be too short to produce 
a toxicity, but the reduced weight gain due to the highest level of vitamin 
A in the second period may be the result of toxicity. 
In the second period, a significant (P<0.01) week x ascorbic acid 
interaction was noted on gains for the noncrossed-over poults, while in 
group 2 (crossed-over), a week x vitamin A quadratic x ascorbic acid inter­
action was significant (P<0.01). These interactions appear to be the 
result of poor sampling of poults at week three, because fewer birds were 
left in the experiment. The reduced numbers of poults in each pen resulted 
in more variation of pen averages. 
Feed consumption (Table 14) was not influenced by either vitamin A or 
ascorbic acid in either group. The combined feed consumption for groups 1 
and 2 is summarized to correspond to the body weight gains reported in the 
same table. Poults receiving the NRC level of vitamin A consumed more 
feed than poults on the other levels of vitamin A during each week of the 
experiment, but this quadratic effect was not significant. A significant 
(P<0.05) period x vitamin A quadratic interaction was noted in group 1, 
but it was not significant in either group 2, or for the combined data. 
Thus the interaction does not appear to be important. 
Feed efficiency (Tahlp Ti) in groups 1 and 2 was not influenced by 
any treatment, but a linear trend was noted for the vitamin A factorial 
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effect of the combined data. The increasing levels of dietary vitamin A 
resulted In a progressive decrease In feed efficiency. 
The three levels of dietary vitamin A resulted In significant 
differences In various parameters of femur development while ascorbic acid 
supplementation, either continuous or crossed-over after two weeks, had no 
Influence on bone development. Table IS contains femur development data 
combined to Illustrate the vitamin A effects on femur weight, femur length, 
femur weight/body weight ratio and the femur weight/femur length ratio. 
The analyses of variance for the above parameters of femur development are 
reported in Tables 50, 51, 52 and 53 of the Appendix. 
Table 15. Effect of vitamin A on femur development - Experiment 3 
Period 1 Period 2 
Dietary Weeks on experiment 
vitamin A 1 2 3 4 Av 
Femur weight (gm) 
hmc 0.377 0.819 1.485 2.281 1.240 
NRC 0.357 0.876 1.373 2.386 1.248 
4xNRC 0.340 0.683 1.237 1.928 1.047 
Av 0.358 0.792 1.365 2.198 
Femur length (mm) 
%NRC 37.5 46.6 55.7 64.6 51.1 
NRC 37.7 48.2 56.2 67.0 52.3 
AxNRC 36.9 45.1 55.4 63.7 50.3 
Av 37.4 46.7 55.8 65.1 
Femur weight/body weight (mg/gm) 
;%NRC 1.484 1.697 1.924 2.014 1.779 
NRC 1.361 1.814 1.806 1.994 1.743 
4XNRC 1.334 1.529 1.644 1.758 1.566 
Av 1.393 1.680 1.791 1.922 
Femur weight/femur length (mg/mm) 
%NRC 10.02 1/.53 26.66 35.30 n n OiC • uw 
NRC 9.43 17.94 24.36 35.54 21.81 
4xNRC 9.21 15.08 22.22 30.23 19.18 
Av 9.55 16.85 24,39 33.69 
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Significant (P<0.01) increases in femur weight after each week of the 
experiment were the result of increased weights (Table 15)• A significant 
(P<0.05) period x vitamin A quadratic interaction was noted in both con­
tinuous ascorbic acid supplementation and the ascorbic acid cross-over 
poults. In period 1, the 4xNRC level of dietary vitamin A resulted in a 
slight depression in femur weight, while in the second period, the 4xNRC 
level resulted in a marked decrease in femur weight. This indicates that 
high levels of vitamin A become progressively more detrimental with time. 
The overall vitamin A effect resulted in a significant quadratic effect 
for the three levels of vitamin A, manifested by the decrease in femur 
weight of poults receiving the 4xNRC level of vitamin A. 
The femur weight/body weight ratio (mg bone/gm body weight) increased 
significantly (P<0.01) between the weeks of the experiment (Table 15). 
This would indicate that the skeletal system is growing faster than the 
soft tissues of the body. The femur weight in relation to body weight 
decreased in a significantly (P<0.01) linear manner for both groups 1 and 
2 as the dietary vitamin A was increased. 
Vitamin A effects on skeletal development changed with length of time 
of the treatment. In the first week, skeletal growth was enhanced by the 
%NB.C level of vitamin A and was decreased as dietary vitamin A was increased. 
In week 2, the NRC level of vitamin A resulted in the best skeletal growth, 
and the highest concentration of vitamin A depressed skeletal growth more 
than did the lowest level of vitamin A. The difference between weeks 1 and 
2 in both grc.ip? nf nnni ts resulted in a significant (P<0.05) week x vitamin 
A quadratic interaction. The femur weight to body weight ratio was 
depressed by the highest level of dietary vitamin A in all periods. 
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Femur length (Table 15) increased by approximately 92 mm per week of 
the experiment and this linear growth response is highly significant 
(P<0.01). A quadratic vitamin A effect on bone length in both groups 1 and 
2 was also significant (P<0.01). Poults receiving the NRC level of vitamin 
A had longer femurs than poults on the other levels of vitamin A, and 
poults fed the 4xNRC vitamin A diets had reduced femur length at each week 
of the experiment. 
Vitamin A treatment effects in both groups 1 and 2 resulted in a 
highly significant linear decrease in the ratio of femur weight to femur 
length (Table 15), but the trend was not noted for every week of the 
experiment. Poults receiving the high vitamin A diet had femurs which 
weighed less per unit length at all ages. The depression of weight per 
length of bone became more pronounced in the last two weeks of the 
experiment as denoted by the significant (P<0.05) period x vitamin A 
linear interaction in group 1. 
Dietary vitamin A produced changes in bone mineralization while 
ascorbic acid had no effect. Table 16 contains the vitamin A effects on 
the ash, calcium, phosphorus and magnesium content of the femur and on 
the calcium/phosphorus ratio. Statistical analyses of these data are 
found in Tables 54, 55, 56, 57 and 58 of the Appendix. 
Ash content (Table 16) of the femur increased significantly (P<0.01) 
during each week of the experiment. Significant (P<0.01) vitamin A 
responses in both groups were shown to be both linear and quadratic in 
nature (Table 54). The highest percentage ash for each week of the 
experiment was noted in poults receiving the ^ NRC level of vitamin A, 
and the lowest ash content for poults on the 4xNRC level of vitamin A. 
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Table 16. Effect of vitamin A on femur mineralization - Experiment 3 
Dietary 
vitamin A 
Period 1 Period 2 
Weeks on experiment 
Av 
%NRC 
NRC 
4xNRC 
Av 
49.23 
48.69 
46.21 
48.04 
Ash (%) 
52.45 
52.66 
47.64 
50.91 
53.25 
52.78 
47.90 
51.31 
54.71 
53.80 
49.79 
52.74 
52.41 
51.98 
47.88 
NRC 
4xNRC 
Av 
17.16 
17.43 
16.29 
16.96 
Calcium (%) 
17.45 
18.52 
16.64 
17.62 
17.97 
18.26 
16.58 
17.60 
17.82 
18.46 
17.33 
17.87 
17.60 
18.17 
16.71 
JgNRC 
NRC 
4xNRC 
Av 
%NRC 
NRC 
4xNRC 
Av 
Phosphorus (%) 
7.85 8.41 8.73 
8.06 8.45 8.72 
7.52 7.64 7.64 
7.81 8.19 8.36 
2.19 
2.18 
2.17 
2.18 
Calcium/phosphorus ratio 
2 .06  
2 .20  
2.18 
2.15 
2 . 0 6  
2.10 
2.17 
2.11 
8 . 8 6  
8.91 
7.93 
8.57 
2.03 
2 .08  
2.17 
2.09 
8.48 
8.53 
7.68 
2.09 
2.14 
2.17 
%NRC 
NRC 
4xNRC 
Av 
Magnesium (%) 
0.373 0.431 0.447 0.479 
0.359 0.437 0.435 0.461 
0.348 0.365 0.370 0.405 
0.360 0.411 0.417 0.448 
0.432 
0.423 
0.372 
Differences in ash values between poults on the ^ NRC and NRC levels of 
vitamin A were not significant at one, two and three weeks, but were 
significant (P<0.05) in the fourth week. As the overall difference in 
bone ash produced by the two lower levels of vitamin A was not different, 
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comparison was made with the 4xNRC group. The difference in bone ash 
between the poults supplemented with 4xNRC dietary vitamin A and the 
two lower levels was highly significant (PcO.OOl) for each week of the 
experiment. 
The significant (P<0.05) interaction between period and vitamin A 
in both groups is the result of a greater depression of bone ash of poults 
on the 4xNRC diets in the third and fourth weeks. Thus the depression 
of bone ash by the high level of vitamin A is accumulative. 
Calcium content of bone increased significantly (P<0.05) from week 
one to week two (Table 16), but no further significant increases were 
noted in the next two weeks. Femur calcium was decreased by both the 
high and low levels of dietary vitamin A when compared with the NRC level. 
Thus a highly significant (P<0.01) quadratic effect of vitamin A on bone 
calcification was demonstrated. 
Bone phosphorus increased significantly (P<0.05) during each week of 
the experiment (Table 16). Vitamin A effects on bone phosphorus were 
highly significant (P<0.01) in both groups 1 and 2 and have been combined 
in Table 16. Differences in phosphorus content of femurs from poults fed 
the JjNRC and NRC diets were nonsignificant, but the 4xNRC diet signifi­
cantly (P<0.01) reduced the phosphorus content from the levels noted for 
the lower vitamin A diets. Period x vitamin A interactions and week x 
vitamin A interactions in group 1 were significant (P<0.05), but this 
appears to be due to an abnormally high phosphorus content in week one 
ffiT nnii 1 fg th® NRC This high phosphorus content would 
appear to be the result of analytical errors and, therefore, not a true 
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treatment effect. Such interactions on phosphorus were not noted in group 
2 which, in period 1, was receiving the same treatments as group 1. 
Magnesium content of the femur (Table 16) increased significantly 
(P<0.01) during each week of the experiment. Increased vitamin A levels 
resulted in highly significant (P<0.01) linear decreases in percent 
magnesium of the femur in both groups 1 and 2. The period x vitamin A 
linear interaction in group 1 was significant (P<0.01), but the same 
interaction was not significant in group 2. Since the interaction is not 
significant in the second group, it would appear that the vitamin A 
effects are the same from period to period. The period x ascorbic acid 
interaction in group 2 was shown to be highly significant (P<0.01) 
statistically (Table 16), but it is thought not to be due to the crossed-
over ascorbic acid treatment. It is probable that the interaction is the 
result of differences in the bone magnesium content of the group of birds 
which was crossed-over. For example, poults with the higher femur 
magnesium in period 1 were also high in period 2 and it appears that they 
were not influenced by the addition of ascorbic acid in period 2. This 
interaction can also be questioned due to the statistical methods employed 
in calculating the mean square. 
The calcium/phosphorus ratio decreased significantly (P<0.05) from 
period 1 to period 2. Difference between weeks in the periods was not 
significant, but decreases in the ratio occurred each week. A slight 
increase in the calcium/phosphorus ratio was related to increasing the 
dietary levels of vitamin A. This linear response was significant (P<0.05) 
in group 1, but not in group 2. The combined vitamin A means for both 
groups were nonsignificant. 
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Ascorbic acid in this experiment had no influence on femur development 
or mineralization, while vitamin A had specific effects upon both femur 
growth and mineralization. The reduction of femur weight and femur weight/ 
body weight ratio in poults receiving the 4xNRC vitamin A diets is the 
result of the lower mineral content of the bone. The calcium/phosphorus 
ratio was not influenced by dietary vitamin A, indicating that difference 
in mineral content of femurs was not the result of alteration in the calci­
fication mechanism. It appears that changes in bone composition that have 
been described could be the result of increased matrix formation or a 
change in rate of bone maturation. Immature bone is less mineralized, has 
a greater metabolic ability and, thus, a greater "turn-over" rate-
Plasma ascorbic acid levels are reported in Table 17 and the analysis 
of variance in Table 59. Data from both groups were combined to demonstrate 
the vitamin A and ascorbic acid effects on plasma ascorbic acid. 
Table 17. Effect of ascorbic acid supplementation on plasma ascorbic acid 
(yg AA/ml) - Experiment 3 
Period 1 Period 2 
Weeks on experiment Vita-
1 2 3 4 min 
Dietary Ascorbic acida A 
vitamin A 0 3000 0 3000 0 3000 0 3000 effect 
%NRC 5.83 23.15 9. 23 28.25 10.03 27.92 14.14 33.55 19.02 
NEC 6.88 23.75 9. 34 20.48 13.01 25.21 13.67 29.65 17.75 
4xNRC 5.54 22.92 8. 06 22.12 11.49 22.68 13.94 27.64 16.80 
Av 6.08 23.27 8. 06 23.62 11.51 25.27 13.92 30.28 
Age 
effect 14. 68 16. 25 18.39 22. 10 
dietary ascorbic acid in ppra. 
40 
The addition of 3000 p.p.m. dietary ascorbic acid resulted in a highly 
significant (P<0.005) increase in plasma ascorbic acid. The increase in 
plasma ascorbic acid when calculated over each week of the experiment 
averaged 15.5 ug per ml. Plasma ascorbic acid of both supplemented and 
nonsupplemented poults increased significantly (P<0.G1) during each week 
of the experiment (Table 17). The increases in plasma ascorbic acid 
between weeks of the experiment were 1.57, 2.14 and 3.70 pg/ml, respectively. 
The cross-over of dietary ascorbic acid had no effect on the plasma 
ascorbic acid as poults fed diets with ascorbic acid in only the first 
period had plasma ascorbic acid levels which corresponded closely to those 
of poults fed ascorbic acid-supplemented diets throughout both periods. 
The addition of exogenous ascorbic acid to the diets in period 2 produced 
a similar increase in plasma ascorbic acid as was noted for group 1. 
A significant (P<0.05) linear decrease in plasma ascorbic acid was 
noted when compared with the log of the increasing dietary vitamin A 
levels. The linear decrease in plasma ascorbic acid due to increasing 
vitamin A was more pronounced in ascorbic acid-supplemented poults than 
in nonsupplemented poults; therefore, an interaction between vitamin A 
linear x ascorbic acid was significant (P<0.05). The interaction of the 
dietary treatments in period 1 reported in the analysis of variance (Table 
59) for group 1 is not significant when the data are combined. These 
interactions appear to be the result of wide variations among pen means that 
result from inadequate sample numbers. 
PlasTTia calclutn and nrngneeinm 1 pvpl B are reported in Table 18 and the 
statistical analyses in Table 60. Calcium and magnesium levels were not 
influenced by any dietary treatment so only the means for each week are 
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reported for each group. Differences between weeks in each period were 
significant for both calcium and magnesium, but there was no difference 
noted between periods. Since no trends are noted overall for weeks, the 
differences do not appear to be biologically important. 
Table 18. Plasma calcium (mg/lOO ml) and magnesium (mg/100 ml) levels -
Experiment 3 
Period 1 Period 2 
Weeks on experiment 
Groups 1 2 3 4 Av 
Plasma calcium 
1 12.12 11.58 12.07 10.15 11.48 
2 12.49 10.84 13.43 9.81 11.64 
Av 12.31 11.21 12.75 9.98 
Plasma magnesium 
1 2.238 2.018 2.442 1.952 2.163 
2 2.419 2.124 2.744 2.021 2.327 
Av 2.328 2.071 2.593 1.986 
Plasma inorganic phosphorus levels are reported in Table 19 and the 
analysis of variance in Table 61. Ascorbic acid had no effect on plasma 
phosphorus in either group of poults, so the data in Table 19 are presented 
to demonstrate the weekly vitamin A effect. 
Table 19. Effects of dietary vitamin A on plasma inorganic phosphorus 
levels - Experiment 3 
Dietary 
vitamin A 
Period 1 Period 2 
Weeks on experiment 
Av 
NRC 
4xNRC 
Av 
H. 06_) 
4.763 
3.906 
4.425 
Plasma phosphorus (mg/100 ml) 
O.UOJ 
6.389 
4.375 
5.575 
o.yoo 
6.438 
4.900 
6.158 
/ .UJO 
7.138 
4.875 
6.058 
o. zza 
6.181 
4.497 
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A significant (P<0.01) linear log-dose response of dietary vitamin A on 
plasma phosphorus was noted in both groups (Table 19). The increasing 
vitamin A levels resulted in a decrease in plasma phosphorus. The phosphorus 
level of plasma increased significantly (P<0.01) in the weeks of period 1, 
but plateaued in the weeks of period 2. 
Experiment 4 
Objectives 
During the later stages of Experiments 2 and 3, a reduction in body 
weight gains was noted for both the high (16000 lU/kg) and low (1000 lU/kg) 
levels of dietary vitamin A. Therefore, a long-term study was conducted 
to determine if these high and low levels of vitamin A would become pro­
gressively more detrimental to the development of both male and female 
poults. Ascorbic acid also was tested in this long-term experiment because 
some benefit on growth was noted in Experiment 1 and a trend of reduced 
bone ash was noted in Experiment 2. 
Experimental design 
Day-old poults of a white strain were obtained from a commercial 
hatchery. Male and female poults were placed in electrically heated 
batteries and pens were randomly assigned six experimental diets. Feed 
and water were available ad libitum. A vitamin A depletion period was not 
used in this experiment because it was theorized that it would have little 
effect on the outcome of a long-term experiment. 
After two weeks, the poults were removed from the batteries and placed 
in floor pens for the remaining 16 weeks of the experiment. The composition 
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of the basal diets (Table 1) was changed after eight and 16 weeks of the 
experiment in order to adjust protein and energy levels. Vitamin A was 
supplemented at 1000, 4000 and 16000 lU/kg and diets will be referred to 
as %NRC, NRC and 4xNRC diets. After eight weeks, an additional 320 lU of 
vitamin A per kg was added to the %NRC diet making a new diet that con­
tained one-third of the NRC requirement of vitamin A (1320 lU/kg). For 
convenience this diet will be referred to as the %NRC diet so that 
continuity between experiments might be maintained. 
Results 
Body weight gains, feed consumption and feed efficiency are reported 
in Tables 20, 21 and 22, respectively. Analysis of variance for body weight 
gains is found in Table 62 while statistical analyses for feed consumption 
and feed efficiency are reported in Table 63. Statistical analyses for 
feed consumption and feed efficiency data contain three less degrees of 
freedom in the error term because one pen of birds had unreasonable feed 
consumption records in the last three periods of the experiment and it was 
thought a feed weighing error was made. Thus the analyses of variance 
were computed using weighted means for missing data. 
Ascorbic acid supplementation had no effect on body weight gains; 
therefore, the data have been combined to demonstrate the effects of 
dietary vitamin A (Table 20). Vitamin A effects are significant (P<0.05) 
and indicate that the NRC diets are better than either the ^ NRC or 4xNRC 
diets in promoting body weight gains. 
The three levels of dietary vitamin A had little effect on overall 
weight gains of the females, but resulted in a reduction in weight gains 
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of males on the %NRC and 4xNRC diets; therefore, the vitamin A x sex inter­
action was significant (P<0.05). The gain in each of the five periods was 
greatest for the males and differences between male and female gains 
increased in each period, thus making the sex x age interaction highly 
significant (P<0.01). 
Table 20. Effects of dietary treatments on body weight gains (gm) -
Experiment 4 
Period Dietary Vitamin A 
(weeks) vitamin A Female Male effects 
0-2 %NRC 210.5 225.7 
NRC 209.6 222.1 
4xNRC 200.7 223.4 
Av 206.9 223.7 
2-5 %NRC 689.4 828.0 
NRC 672.2 853.3 
4xNRC 648.7 765.8 
Av 670.1 815.7 
5-8 %NRC 1099.2 1485.1 
NRC 1335.4 1715.8 
4xNRC 1271.2 1599.6 
Av 1235.2 1600.2 
8-12 %RC 2150.4 2733.9 
NRC 2217.6 3061.2 
4xNRC 2168.5 2925.3 
Av 2178.8 2906.8 
12-18 %NRC 2683.0 3966.7 
NRC 2453.1 4155.2 
4xNRC 2611.9 3810.0 
Av 2582.7 3977.3 
Factorial effects 
%NRC 1366.5 1847.9 1607.2 
NRC 1377.6 2001.5 1689.5 
4xNRC 1380.2 1864.8 1622.6 
Sex effect 1374.8 1904.8 
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Table 21. Effects of dietary treatments on feed consumption (gm) -
Experiment 4 
Period Dietary 
(weeks) vitamin A Female Male 
0-2 %NRC 290 304 
NRC 296 310 
4xNRC 274 298 
Av 287 304 
2-5 kNRC 1166 1360 
NRC 1143 1250 
4xNRC 1071 1252 
Av 1127 1288 
5-8 %NRC 2346 3111 
NRC 2460 3530 
4xNRC 2559 2998 
Av 2454 3213 
8-12 N^RC 5240 6624 
NRC 5561 7777 
4xNRC 5441 6978 
Av 5401 7126 
12-18 WRC 12766 17327 
NRC 11503 18937 
4xNRC 12975 16293 
Av 12497 17519 
Sex effect 4225 5890 
Feed consumption (Table 21) was not altered by any dietary treatment, 
but males consumed significantly (P<0.01) more feed than females in all 
periods, and the increase was greater in each period, making the sex x age 
interaction significant (P<0.005) for feed consumption. 
Feed efficiency (Table 22) was not influenced by any dietary treatment 
or by the sex of the poults, but feed efficiency decreased significantly 
with each period (P<0.005). A significant (P<0.005) sex x period inter­
action was the result of marked reduction or reed efficiency by Lue lemalc» 
in the 12- to 18-week period. Females were nearing mature weight in the 
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Table 22. Effects of dietary treatments on feed efficiency - Experiment 4 
Period Dietary 
(weeks) vitamin A Female Male 
0-2 %NRC 1.38 1.35 
NRC 1.41 1.40 
4xNRC 1.36 1.33 
Av 1.39 1.36 
2-5 %NRC 1.69 1.65 
NRC 1.70 1.47 
4xNRC 1.66 1.64 
Av 1.68 1.58 
5-8 %NRC 2.16 2.13 
NRC 1.87 2.06 
4xNRC 2.01 1.88 
Av 2.03 2.02 
8-12 %NRC 2.49 2.43 
NRC 2.51 2.54 
4xNRC 2.51 2.39 
Av 2.49 2.45 
12-18 %NRC 4.78 4.37 
NRC 4.85 4.54 
4xNRC 4.96 4.27 
Av 4.86 4.39 
Sex effect 2.46 2.36 
last period and, therefore, their rate of gain was decreasing and more 
nutrients were going for maintenance than for production of body mass. 
Data for femur weight, femur length, femur weight/length ratio and 
femur weight/body weight ratio are found in Tables 23, 24, 25 and 26, 
respectively and the analyses of variance for all of the above parameters 
are reported in Table 64. 
Dietary vitamin A resulted in a significant (P<0.01) quadratic effect 
on femur weight; that is, the NRC level of dietary vitamin A resulted in 
hea-if-îpr fpTTiurs than either the %NRC or 4xNRC diets. The vitamin A x sex 
interaction was significant (P<0.05) Indicating that males on the %NRC and 
4xNR.C vitamin A diets had femur weight restricted to a greater extent than 
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Table 23. Effects of dietary treatments on femur weight (gm) -
Experiment 4 
Vitamin Ascorbic 8 weeks 12 weeks Vitamin A 
A acid (ppm) Female Male Female Male effects 
%NRC 0 
3000 
4.6750 
4.0300 
6.0000 
5.0650 
9.2100 
8.3700 
11.6200 
9.5650 
7.3169 
NRC 0 
3000 
4.8400 
5.1250 
6.3100 
6.5450 
9.7300 
9.4250 
14.7650 
12.9400 
8.7100 
4xNRC 0 
3000 
4.7950 
4.6500 
5.8150 
5.7750 
9.1250 
8.9300 
14.3050 
13.9350 
8.4163 
Sex X age 4.6858 5.9183 9.1317 12.8550 
Age effect 5.3020 10.9930 
did females. It appears that by week 12, femur weights from poults on the 
4xNRC level of vitamin A are not restricted as they were in the first eight 
weeks. This is accounted for by males on the 4xNRC level having femur 
weights slightly greater than those of controls in the 12th week, thus 
making the three-factor interaction between vitamin A x sex x age signifi­
cant (P<0.05). Addition of 3000 p.p.m. ascorbic acid resulted in a 
significant (P<0.01) reduction of femur weight In both males and females. 
Femur length (Table 24) was depressed by both the WRC and 4xNRC levels 
of dietary vitamin A making a quadratic effect for vitamin A significant 
(P<0.01). Addition of 3000 p.p.m. ascorbic acid to the diets resulted in 
a significant (P<0.05) reduction in femur length. As expected, males had 
significantly longer (P<0.001) femurs than females at both eight and 12 
weeks of age. 
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Table 24. Effects of dietary treatments on femur length (cm) - Experiment 4 
Vitamin Ascorbic 8 weeks 12 weeks , Vitamin A 
A acid (ppm) Female Male Female Male effects 
0 8.24 8.91 10.06 10.96 
3000 8.09 8.56 9.82 10.27 
NRC 0 8.48 9.19 10.55 11.62 
3000 8.71 9.31 10.44 11.27 
4xNRC 0 8.59 9.16 10.35 11.71 
3000 8.32 9.01 10.31 11.68 
Age effect 8.71 10.75 
9.36 
9.94 
9.89 
Table 25. Effects of dietary treatments on femur weight/femur length ratio 
(mg/mm) - Experiment 4 
Vitamin 
A 
Ascorbic 
acid (ppm) 
8 weeks 12 weeks 
Female Male Female Male 
Vitamin A 
effects 
%NRC 
NRC 
4xNRC 
0 
3000 
0 
3000 
0 
3000 
56.95 
49.80 
56.90 
58.65 
55.70 
56.15 
67.30 
59.05 
68.50 
70.25 
63.40 
63.95 
91.65 
85.10 
92.15 
90.25 
88.25 
86.65 
106.00 
92.25 
126.90 
113.85 
122.10 
119.25 
76.01 
84.68 
81.93 
Age X sex 
Age effect 
55.69 65.40 
60.55 
89.01 113.39 
101.20 
Quadratic vitamin A effects noted on femur weight and femur length 
(Table 25) were also significant (P<0.01) when considering the weight per 
length of the femur. Poults fed the NRC diets had heavier bones per mm 
length than did poults on other diets, indicating treatment effects on 
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the bone remodeling process. Ascorbic acid supplementation resulted in a 
significant (P<0.01) reduction of femur weightrlength ratio. Bone apposi­
tion occurred at a faster rate than the bone elongation between eight and 
12 weeks of age resulting in a highly significant (P<0.001) increase in 
ratio of these parameters with age. Males had a greater increase in rate 
of bone mass deposition than did females between eight and 12 weeks 
resulting in a highly significant (P<0.01) sex x age interaction. 
Both dietary vitamin A and ascorbic acid influenced the femur weight 
relative to body weight (Table 26). 
Table 26. Effects of dietary treatments on femur weight/body weight ratio 
(mg/gm) - Experiment 4 
Vitamin Ascorbic 8 weeks 12 weeks Vitamin A 
A acid (ppm) Female Male Female Male effects 
^RC 0 
3000 
2.280 
2.090 
2.175 
2.205 
2.155 
2.145 
2.280 
2.215 
2.193 
NRC 0 
3000 
2.260 
2.165 
2.290 
2.350 
2.175 
2.045 
2.495 
2.355 
2.267 
4xNRC 0 
3000 
2.190 
2.120 
2.230 
2.305 
2.180 
2.100 
2.500 
2.480 
2.263 
Age effect 2. 222 2.260 
The ^ NRC level of dietary vitamin A resulted in a significant (P<0.05) 
reduction in the relative weight when compared with the two higher levels of 
vitamin A. A reduction of the relative femur weight ratio by the addition 
of 3000 p.p.m. ascorbic acid was also significant (P<0.05). Females also 
had smaller femurs per unit body weight mass with the differences between 
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sexes being highly significant (P<0.0Q5). The ratio of femur weight to 
body weight was essentially the same for both the eight and 12-week-old 
poults. Three levels of dietary vitamin A had little effect on the amount 
of bone per body mass in females, but an increase in bone per body mass 
was noted by increasing dietary vitamin A in the males, thus making the 
vitamin A x sex interaction significant (P<0.01). Femur weight/body weight 
ratio was depressed significantly (P<0.05) by the addition of 3000 p.p.m. 
ascorbic acid to the diet, with the ratio being depressed more in females 
than in males. Therefore, the ascorbic acid x sex interaction was signifi­
cant (P<0.05). 
Bone ash content of femur was decreased by the %NRC and 4xNRC levels 
of dietary vitamin A (Table 27) making the quadratic effect of vitamin A 
significant (P<0.01). Dietary ascorbic acid had no influence on the overall 
mineralization of bones. Sex differences on bone ash were not apparent, 
but a 1.44% increase in bone ash was noted between poults of eight and 12 
weeks of age, making the age effect highly significant (P<0.005). 
Table 27. Effects of dietary treatments on bone ash - Experiment 4 
Vitamin Ascorbic 8 weeks 12 weeks Vitamin A 
A acid (ppm) Female Male Female Male effects 
%NRC 0 
3000 
56.53 56.88 
56.31 55.53 
57.57 58.15 
56.24 57.73 
56.87 
NRC 0 
3000 
56.02 56.32 
57.07 56.46 
59.93 58.73 
57.36 58.07 
57.49 
4xNRC 0 
3000 
55.70 55.34 
56.16 57.12 
57.12 57.32 
55.93 56.13 
56.35 
Age effect 56.18 57.62 
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Calcium, phosphorus and the calcium/phosphorus ratio of femurs are 
reported in Tables 28, 29 and 30, respectively, and the analyses of variance 
for these parameters of bone mineralization are presented in Table 65. 
Calcium content of femurs was not influenced by any dietary treatment, but 
a slight increase in percent calcium was noted with increasing levels of 
dietary vitamin A. No difference in calcium content of femurs was noted 
for either sex, but a significant (P<0.05) increase of 0.45% was noted as 
a result of an age difference. Femur phosphorus content was not influenced 
by ascorbic acid, vitamin A, age or by the sex of the bird. 
Table 28. Effects of dietary treatments on the percent calcium of the 
femur - Experiment 4 
Vitamin Ascorbic 8 weeks 12 weeks Vitamin A 
A acid (ppm) Female Male Female Male effects 
#RC 0 
3000 
18.08 18.76 
18.29 17.99 
19.02 18.04 
18.30 17.97 
18.30 
NRC 0 
3000 
17.64 18.16 
18.04 17.99 
18.98 18.77 
19.30 17.76 
18.32 
4xNRC 0 
3000 
18.37 18.66 
18.63 18.51 
19.55 19.45 
19.19 18.19 
18.82 
Age effect 18.26 18.71 
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Table 29. Effects of dietary treatments on the percent phosphorus of the 
femur - Experiment 4 
Vitamin Ascorbic 8 weeks 12 weeks Vitamin A 
A acid (ppm) Female Male Female Male effects 
^NRC 0 
3000 
9.57 
10.13 
10.79 
9.96 
9.98 
10.21 
10.55 
10.05 
10.15 
NRC 0 
3000 
10.60 
10.92 
10.17 
10.49 
11.23 
11.13 
10.38 
10.50 
10.67 
4xNRC 0 
3000 
9.77 
9.75 
9.64 
9.42 
9.96 
10.04 
9.96 
10.07 
9.82 
Age effect 10. 09 10.34 
Table 30. Effects of dietary treatments on 
femurs - Experiment 4 
the calcium/phosphorus 1 ratio of 
Vitamin Ascorbic 8 weeks 12 weeks Vitamin A 
A acid (ppm) Female Male Female Male effects 
%NRC 0 
3000 
1.890 
1.810 
1.745 
1.810 
1.910 
1.795 
1.720 
1.795 
1.809 
NRC 0 
3000 
1.660 
1.665 
1.709 
1.715 
1.695 
1.735 
1.830 
1.700 
1.722 
4xNRC 0 
3000 
1.890 
1.910 
1.950 
1.975 
1.980 
1.910 
1.955 
1.810 
1.922 
Age effect 1.817 1.819 
The Ca/P ratio was influenced by a significant (P<0.05) quadratic 
effect of vitamin A. Poults receiving the NRC level of vitamin A had a 
lower calcium to phosphorus ratio than did poults receiving the %NRC or 
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4xNRC levels of vitamin A (Table 30) . The calcium:phosphorus ratio was not 
influenced by either age, sex or dietary ascorbic acid. 
The magnesium content of femur is reported in Table 31 and analysis of 
variance in Table 66. Femur magnesium levels were not influenced by the 
dietary treatments imposed, but a possible linear decrease in femur mag­
nesium as a result of increasing levels of dietary vitamin A was suggested 
from the data. No differences in femur magnesium levels were found as the 
result of either sex or age differences of poults. 
Table 31. Effects of dietary treatments on the percent magnesium of the 
femur - Experiment 4 
Vitamin Ascorbic 8 weeks 12 weeks Vitamin A 
A acid (ppm) Female Male Female Male effects 
hmc 0 
3000 
0.470 
0.495 
0.455 
0.515 
0.480 
0.550 
0.440 
0.490 
0.487 
NRC 0 
3000 
0.485 
0.495 
0.490 
0.495 
0.435 
0.490 
0.435 
0.475 
0.475 
4xNRC 0 
3000 
0.470 
0.425 
0.500 
0.420 
0.450 
0.500 
0.475 
0.460 
0.463 
Age effect 0.483 0.467 
Plasma ascorbic acid of turkeys at eight, 12 and 18 weeks of age is 
reported in Table 32 and the analysis of variance in Table 67 of the 
Appendix. Plasma ascorbic acid was significantly (P<0.005) increased by the 
addition of 3000 p.p.m. dietary ascorbic acid. Ascorbic acid supplementa­
tion increased blood levels from 13.10 to 21.67 yg AA/ml plasma. Neither 
dietary levels of vitamin A nor sex of the bird had any influence on levels 
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of plasma ascorbic acid. Plasma ascorbic acid increased significantly 
(P<0.01) with the age of the poults. 
Table 32. Effects of dietary treatments on plasma ascorbic acid levels 
(vig AA/ml plasma) - Experiment 4 
Vita- Female Male Vita- Ascorbic Vitamin 
Age 
wks 
min 
A 
Ascorbic acid Av min 
age A 
acid A 
av 0 3000 0 3000 0 3000 
8 %NRC 5.50 10.95 6.05 12.80 NRC 11.61 20.84 16.23 
NRC 10.65 14.70 6.40 15.50 NRC 13.92 21.45 17.69 
4xNRC 9.20 14.50 4.20 12.60 4xNRC 13.76 21.67 18.24 
10.25 
Av AA 13.10 21.67 
12 %NRC 9.60 17.70 13.35 12.80 
NRC 11.25 13.80 15.20 18.20 
4xNRC 14.00 26.45 13.50 19.30 
15.89 
18 %NRC 18.70 34.20 16.50 18.40 
NRC 21.40 21.40 18.65 31.60 
4xNRC 21.45 28.90 20.25 34.60 
26.01 
Plasma calcium, inorganic phosphorus and magnesium are reported in 
Tables 33, 34 and 35, respectively, and analyses of variance for these 
parameters are found in Table 67 of the Appendix. Plasma calcium was not 
affected by any combination of vitamin A and ascorbic acid or by any 
interaction between these vitamins. Sex and age of poults had no effect 
on plasma calcium. A significant (P<0.05) interaction between vitamin A 
and sex was noted. Plasma calcium levels of females on the %NRC, NRC and 
4xNRC dietary levels of vitamin A were 12.55, 12.67 and 12.72 mg percent, 
rsspectlvely, 2nd Itî insles the corrfspnnHlne valnmm were 13.51. 12.40 and 
12.20 mg percent, respectively. Thus, calcium levels increased in females 
and decreased in males as dietary vitamin A was increased. 
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Table 33. Effects of dietary treatment on plasma calcium levels (mg/100 
ml) - Experiment 4 
Vita-
Age min 
wks A 
Female Hale 
Ascorbic acid 
3000 0 3000 
Av 
age 
Vita­
min 
A 
Ascorbic 
acid 
3000 
Vitamin 
A 
av 
8 %NRC 
NRC 
4xNRC 
11.56 
13.12 
13.25 
14.06 
12.62 
12.56 
13.56 
12.12 
12.81 
15.06 
13.43 
13.56 
NRC 
4xNRC 
13.14 
12.61 
12.71 
12.31 
13.44 
12.36 
12.62 
AA av 12.54 12.81 
13.03 
12.53 
12.46 
12 
NRC 
4xNRC 
11.25 
13.98 
11.88 
12.97 
12.33 
12.45 
12.41 
11.66 
11.81 
12.15 
11.36 
11.47 
12.14 
%NRC 
NRC 
4xNRC 
Female 
12.55 
12.67 
12.72 
Male 
13.51 
12.40 
12.20 
18 %NRC 
NRC 
4xNRC 
12.56 
12.03 
12.82 
12.90 
11.93 
13.38 
14.33 
13.33 
11.28 
13.53 
12.48 
12.30 
12.74 
Sex effect 12.65 12.70 
Table 34. Effects of dietary treatment on plasma phosphorus levels (mg/100 
ml) - Experiment 4 
Vita­ Female Male Vita­ Ascorbic Vitamin 
Age min Ascorbic acid Av min acid A 
wks A 0 3000 0 3000 age A 0 3000 av 
8 %NRC 7.63 7.48 8.11 7.82 ^NRC 9.18 9.05 9.12 
NRC 7.73 7.78 8.74 7.71 NRC 9.69 8.82 9.26 
4xNRC 7.77 7.27 6.81 8.22 4xNRC 8.86 8.76 8.81 
7.75 
AA av 9.25 
12 %NRC 8.85 8.81 8.48 10.80 
NRC 8.98 7.69 14.08 10.87 Age Female Male 
4xNRC 7.75 9.68 12.58 10.17 8 wk 7.61 7.90 
9.87 12 wk 8.85 11.16 
18 wk 10.28 8.85 
18 %NRC 12.78 9.39 9.53 10.03 
11.7/1 9.78 6. 89 q.i? 
4xNRC 9.42 8.55 8.87 8.68 
9.56 
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Plasma inorganic phosphorus (Table 34) was not influenced by diet, 
but it increased significantly (P<0.05) from 7.75 mg percent at eight 
weeks to 9.87 mg percent at 12 weeks of age, and then decreased to 9.56 
mg percent at 18 weeks of age. 
Plasma magnesium levels (Table 35) were not influenced by either 
dietary treatments, age or sex of the poults. 
Table 35. Effects of dietary treatment on plasma magnesium levels (mg/lOO 
ml) - Experiment 4 
Vita­ Female Male Vita­ Ascorbic Vitamin 
Age min Ascorbic acid Av min acid A 
wks A 0 3000 0 3000 age A 0 3000 av 
8 %NRC 1.462 1.745 1.687 1.874 kmc 1.613 1.697 1.655 
NRC 1.683 1.568 1.477 1.704 NRC 1.621 1.612 1.616 
4xNRC 1.683 1.558 1.583 1.778 4xNRC 1.597 1.661 1.629 
1.650 
AA av 1.610 1.657 
12 %NRC 1.530 1.525 1.665 1.568 
NRC 1.800 1.620 1.505 1.477 
4xNRC 1.545 1.740 1.507 1.522 
1.583 
18 %NRC 1.680 1.687 1.655 1.785 
NRC 1.567 1.653 1.697 1.650 
4xNRC 1.747 1.717 1.575 1.650 
1.667 
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DISCUSSION 
Body weight gains were improved significantly (P<0.05) by the addition 
of dietary ascorbic acid in Experiment 1. The increasing dietary ascorbic 
acid levels of 0, 30, 300, 1500 and 3000 p.p.m. promoted body weight gains, 
thus producing a linear log-dose response. It is believed that the log-dose 
response is indicative of a positive ascorbic acid effect. During the first 
period of Experiment 2, ascorbic acid supplementation of 300 and 3000 p.p.m. 
improved body weight gains, but this trend was not statistically signifi­
cant. In the second period of Experiment 2, there were no ascorbic acid 
effects observed on weight gains. In Experiments 3 and 4, there were no 
improvements in body weight gains by the addition of 3000 p.p.m. ascorbic 
acid to the basal diet. 
In Experiment 1, dietary ascorbic acid produced a significant (P<0.005) 
increase in feed consumption along with a significant (P<0.005) decrease in 
feed efficiency. In period 1 of Experiment 2, feed consumption increased 
significantly (P<0.05) when ascorbic acid was added to the basal diet, but 
ascorbic acid did not influence feed utilization. Feed consumption and 
feed efficiency were not influenced by dietary ascorbic acid in either 
Experiments 3 or 4. Thus it appears, if exogenous ascorbic acid results 
in an increased feed consumption, then it also results in a decreased feed 
efficiency. Data on feed consumption and feed utilization by rapidly 
growing poults as influenced by dietary ascorbic acid supplementation of 
practical type diets have not been previously reported. 
Since body weight gains, feed consumption and feed efficiency are 
closely related, it would appear that the primary effect of dietary 
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ascorbic acid on production parameters, when it occurs, is manifested by an 
increase in feed intake which results in improved body weight gains. From 
this series of experiments, it is concluded that environmental factors may 
potentiate ascorbic acid responses and that ascorbic acid effects are only 
short term even if long-term ascorbic acid supplementation is conducted. 
Since exogenous ascorbic acid appeared to elicit only a temporary response, 
it might suggest that poults adjusted the mechanism of metabolic regulation 
of ascorbic acid metabolism. 
Ascorbic acid supplementation resulted in a significant (P<0.005) 
increase in plasma ascorbic acid in all experiments (Tables 3, 10, 17 and 
32). Plasma ascorbic acid values for poults on either the basal diet or 
diets supplemented with 3000 p.p.m. ascorbic acid were quite similar in 
Experiments 1, 2 and 3, with the plasma value for controls ranging from 
9.1 to 9.6 yg AA/ml, while plasma levels of the supplemented group ranged 
from 25.3 to 26.1 yg AA/ml. 
In Experiment 1, dietary ascorbic acid levels of 30, 300, 1500 and 
3000 p.p.m. resulted in a significant (P<0.01) linear log-dose increase 
in plasma ascorbic acid. From Figure 1, it is apparent that 30 p.p.m. 
dietary ascorbic acid had very little effect on plasma ascorbic acid. 
It is further noted that there was no improvement in body weight gain for 
poults on the 30 p.p.m. diets. In Experiment 2, the dietary levels of 
0, 30, 300 and 3000 p.p.m. ascorbic acid resulted in a highly significant 
(P<0.005) linear log-dose increase in plasma ascorbic acid. The factorial 
effects (Table 10) for ascorbic acid in Experiment 2 indicate that 30 
p.p.m. dietary ascorbic acid would increase plasma levels by 1.67 yg AA/ml, 
but this is not significant. It should also be pointed out that weight 
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gains (Table 7) were not improved by 30 p.p.m. ascorbic acid, but the 
higher levels of vitamin supplementation appeared beneficial. These data 
indicate that the level of dietary supplementation.of ascorbic acid must 
be at a level such as to produce a significant increase in plasma ascorbic 
acid before a growth response would occur, and an increase in plasma 
levels does not insure a positive growth response. 
Since dietary ascorbic acid results in higher plasma ascorbic acid 
concentrations, this work is in agreement with previous reports (Dorr and 
Nockels, 1971; Herrick and Nockels, 1969). The significant linear log-
dose response to graded levels of ascorbic acid is similar to that noted 
by Giroud e^ (1938) for man and guinea pigs. Injected poults in 
Experiment 1 had slightly elevated plasma ascorbic acid levels, but the 
increase was nonsignificant. Satterfield (1945) reported subcu­
taneous injections of ascorbic acid greatly increased blood ascorbic acid, 
but elevated blood levels were transitory and blood ascorbic acid returned 
to basal levels within two hours of injection. 
Plasma ascorbic acid of control and supplemented poults in Experiments 
3 and 4 increased significantly with the age of the poult. While this is a 
statistically significant observation, there is evidence that makes such an 
effect questionable. Scrimshaw e£ al. (1949) and Simmonds (1965) reported 
whole blood ascorbic acid values for various breeds of chickens and con­
cluded that breed differences might occur at any one sampling time, but the 
ranking of breeds would differ at various ages. Dorr and Nockels (1971) 
reported that plasma ascorbic acid of nonsupplemented pullets tended to 
increase until 19 weeks of age and then a 55% decrease was noted by 32 
weeks. Five-year-old hens had plasma ascorbic acid levels that were 
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intermediate between values reported for 19- and 32-week-old pullets, 
indicating that plasma ascorbic acid does not continue increasing through­
out life. 
The recent paper of Nestor et (1972) is the only work published 
in which blood ascorbic acid levels for ascorbic acid-supplemented and non-
supplemented turkeys are reported. They found that neither 83 nor 330 
p.p.m. dietary ascorbic acid statistically increased plasma ascorbic acid 
when based on four sampling times within a 48-day trial, thus making their 
results disagree with the results of Experiments 1, 2 and 3. But, in 
Experiment 4, different plasma ascorbic acid levels due to treatment were 
not as great as those found in the first three experiments. Thus, there 
appear to be undetermined factors which can affect blood ascorbic acid 
levels and which make a given group of birds respond in a similar manner 
at given sampling times. 
Ascorbic acid is known to be required for the hydroxylation of proline 
for the production of the collagen matrix of bone, but effects of excess 
exogenous ascorbic acid on the i^ vivo development of bone have not been 
studied. This series of experiments indicates that short-term supplementa­
tion with various levels of dietary ascorbic acid does not alter the normal 
development of bone in either the growth or mineralization phase, but 
ascorbic acid effects on bone development become apparent between eight and 
12 weeks. 
In Experiment 4, femur weight and length were found to be depressed by 
Llie suppleniantaticn cf 3000 ? = ««corblc acid. Further evidence for an 
ascorbic acid effect on bone development is demonstrated by the significant 
variations in both the femur weight/body weight ratio and the femur 
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weight/femur length ratio. Since ascorbic acid did not alter the chemical 
composition of bone, it would appear that the effect is on the overall bone 
mass. This suggests an ascorbic acid effect on the endochondral elongation 
process of bone growth along with an effect on either the process of apposi­
tion or reabsorption. 
The four experiments in this study have demonstrated that bone mineral­
ization is not influenced by any amount of exogenous ascorbic acid because 
bone ash, calcium, phosphorus and magnesium contents were unaltered. The 
calcium, magnesium and phosphorus concentrations in plasma are not 
influenced by exogenous ascorbic acid. 
Thornton and Omdahl (1969) demonstrated that chicks injected with 
ascorbic acid mobilize labeled bone calcium. An explanation might be that 
exogenous ascorbic acid is resulting in a faster turn-over of the calcified 
matrix. This would account for the normal ash values in the bones that 
were shown to be lighter and had depressed femur weight/femur length ratios. 
Since turn-over of collagen molecules is known to be a slow process, this 
would account for the long time period needed to demonstrate a positive 
ascorbic acid effect on the vivo development of bone. 
The three vitamin A treatments that were imposed in Experiments 2 ,  
3 and 4 influenced the body weight gain response. The ^ NRC diet (1000 
lU/kg) produced hypo-vitaminosis A as determined by the decreased response 
in body weight gains, with the time required to produce the response being 
influenced by the pre-experimental depletion period. The 4xNRC diet 
(16000 lU/ke) resulted in a hyper-vitaminosis A. as determined by poor body 
weight gains. 
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The time periods required to produce the detrimental effects of a 
marginal deficiency and a toxicity of vitamin A are important in the 
evaluation of the nutritive requirements of growing turkeys. Data from 
Experiments 2 and 4 indicate that both the AjNRC and 4xNRC diets stimulated 
body weight gain responses for the first two to three weeks, but in 
subsequent weeks of the experiment, these diets began restricting the 
ability of the poults to make maximal weight gains. Thus, in short-term 
experiments, where body weights are used to measure the effectiveness of 
the vitamin A supplementation, these results would not indicate a treat­
ment difference as body weights would be unaffected by diets. 
The marginal vitamin A deficiency produced with the %NRC diet was 
such that it slowed the rate of growth, but did not stop growth. Hens 
fed the J^NRC diet in Experiment 4 made compensatory gains in the 12 to 18 
week period, but the males were more sensitive to the vitamin A treatments 
and body weights of males at 18 weeks were significantly reduced. It is 
possible that if males were continued on the experiment for an additional 
six weeks, compensatory growth would occur as it did in females. The 
data suggest that older, slower-growing turkeys have a lower requirement 
for vitamin A than is currently recommended. 
The effect of the three levels of dietary vitamin A used in Experi­
ments 2, 3 and 4 on feed consumption and feed efficiency was generally 
nonsignificant, although a treatment effect was noted in period 1 of 
Experiment 2. The data from the three experiments indicate that feed 
consumption is related to body weight gains. In general, when a given 
group of birds made maximal body weight gains, they also consumed more 
feed. The feed efficiency appears to be related to the level of vitamin A 
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supplementation because efficiency was depressed by the increasing levels 
of dietary vitamin A. 
The three dietary levels of vitamin A produced statistically signifi­
cant effects on femur development and mineralization, but effects appear 
random and not consistent among experiments. 
In Experiments 3 and 4, femur weights and femur lengths were 
significantly decreased by the hypo- and hyper-vitaminosis A conditions, 
and the responses reflected treatment effects on body weight gains. 
Femur weights in Experiment 2 were improved by the 2«NRC and 4xNRC diets; 
thus the experiments are contradictory. Also, data from Experiment 2 were 
based on more individual observations, making it a better estimate of 
possible vitamin A effects on bone development. The responses, with 
regard to femur weight and femur length in Experiments 3 and 4, were 
comparable, indicating that the length of treatment was not a factor in 
producing the noted effects. 
Havivi and Wolf (1967) reported that severely vitamin A-deficient 
chicks produced longer and thicker bones that weighed less on a dry weight 
basis when compared with controls. The marginal vitamin A deficiency 
produced in Experiments 2, 3 and 4 did not substantiate the observation 
of Havivi and Wolf (1967) because femur length was shorter in deficient 
poults. The discrepancies noted appear to be related to the severity of 
vitamin A restriction, which would influence the length of time required 
to develop treatment effects. 
The mild hyper-vitaminosis A that developed in poults fed the 4xNRC 
diets resulted in reduced femur weight and femur length. These effects 
appear to be related to the treatment effects on the growth rate, but the 
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femur weight:body weight ratios are depressed, indicating that bone mass 
is reduced more than body mass. In Experiment 4, the reduction of femur 
weight/femur length ratio indicates a thinning of the bone due to the 
hyper-vitaminosis A, and the vitamin A effect is on the intramembranous 
development of bone. These results are similar to those reported by 
Wolke et (1968) on the effect of mild vitamin A toxicity in swine. 
The three dietary levels of vitamin A used in Experiments 2, 3 and 
4 resulted in significant changes in the mineral content of femurs. In 
Experiments 2 and 3, an inverse relationship between bone ash and vitamin 
A supplementation resulted. Bone ash values in Experiment 4 were 
depressed by both the ^NRC and 4xNRC diets, thus producing a quadratic 
effect for vitamin A. The 4xNRC diets reduced the ash content of femurs 
in all experiments and the evidence suggests a possible effect on matrix 
production as the Ca/P ratio did not implicate impairment of the 
mineralization process. Calcium, phosphorus and magnesium data correspond 
closely to the ash data and, therefore, do not add any information on the 
effect of vitamin A on bone development. 
Plasma calcium and magnesium levels were not influenced by the dietary 
levels of vitamin A imposed in these studies, but plasma inorganic phos­
phorus levels were depressed by the 4xNRC levels of dietary vitamin A and 
the effect was significant (PcO.Ol) in Experiment 3. 
Taylor ££ al^. (1968) reported that dietary vitamin A in excess of the 
requirement increased plasma inorganic levels in chicks, while Belanger 
and Clark (1967) reported decreases in plasma inorganic phosphorus levels 
in rats fed excessive vitamin A. Thus, the results indicate that turkeys 
do not respond to excessive vitamin A in the same manner as do chickens. 
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Plasma ascorbic acid levels in Experiment 2 were influenced by an 
interaction between the dietary levels of vitamin A and ascorbic acid. 
Vitamin A-deficient poults that were not supplemented with ascorbic acid 
had reduced plasma ascorbic acid levels. This confirms the report of 
Nockels e^ al. (1971). Reduced plasma ascorbic acid may be the result 
of the effect of vitamin A deficiency on kidney tissue which may result 
in impaired biosynthesis of ascorbic acid. The carrying capacity of 
plasma might be implicated because composition of plasma and urine is 
altered in vitamin A deficiency (Webb ^  , 1968). 
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CONCLUSIONS 
Data from these studies indicate that supplementation of practical 
turkey diets with ascorbic acid is unwarranted, but the positive growth-
promoting effects of ascorbic acid in Experiment 1 indicate a need for 
more studies on the role of ascorbic acid metabolism in poultry. 
Long-term ascorbic acid supplementation (3000 p.p.m.) influenced the 
development of the femur as femurs tended to be lighter, shorter and were 
a significantly smaller percentage of the body weight. IVhile these data 
tend to indicate that long-term ascorbic acid supplementation may be 
harmful to bone development, it is theorized that exogenous ascorbic acid 
may maintain the bone tissue in a more active and responsive state. If 
this theory is correct, exogenous ascorbic acid may afford some protection 
against the occurrence of leg weakness problems. 
Exogenous ascorbic acid did not influence the mineralization of bones 
or alter the plasma calcium, magnesium and phosphorus levels. Ascorbic 
acid absorption is readily detected by measuring plasma ascorbic acid with 
the increase in plasma ascorbic acid being related to the log of the 
dietary ascorbic acid. 
While these studies confirm the NRC (1971) recommendations for vitamin 
A, they stress the need for more research with regard to the minimum and 
maximum levels of dietary vitamin A that can be tolerated by growing 
turkeys. The data indicate that 1000 lU/kg (%NRC) and 16000 lU/kg (4xNRC) 
promote the poults' ability to make weight gains during the first few 
weeks but, ultimately, a growth depression results. Such data indicate 
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that the level of dietary vitamin A may influence the utilization of 
stored vitamin A. 
The common practice of some nutritionists to recommend levels of 
vitamin A in excess of the requirement is questioned, because data from 
these experiments demonstrate that when vitamin A is provided at four 
times the recommended level, a growth depression results. From the data, 
it is concluded that 16000 lU of vitamin A per kilogram of diet is a 
toxic level for turkeys. 
The three levels of dietary vitamin A used in this study produced 
significant effects on femur development and mineralization, but they 
were random and not consistent between experiments. As the dietary levels 
of vitamin A used in this study to produce the hypo- and hyper-vitamin 
A conditions were not of the magnitude used in other experimental studies, 
they did not produce the classic effects upon bone metabolism. 
It is important to point out that bone development was altered by 
dietary vitamin A levels in an otherwise adequate diet. Therefore, it 
could be speculated that diets either inadequate or imbalanced with regard 
to nutrients known to influence bone development would be influenced by 
possible vitamin A interactions. 
68 
BIBLIOGRAPHY 
Arscott, G. H., P. Rachapaetayakom, P. E. Bernier and F. W. Adams, 1962. 
Influence of ascorbic acid, calcium and phosphorus on specific 
gravity of eggs. Poultry Sci., 41:485-488. 
Baker, J. R., J. McC. Howell and J. N. Thompson, 1967. Hypervitaminosis A 
in the chick. Br. J. Exp. Path., 48:507-512. 
Bamicot, N. A., and S. P. Datta, 1956. Vitamin A and bone. In The 
Biochemistry and Physiology of Bone, pp. 507-537. H. G. Bourne, ed. 
Academic Press, Inc., New York. 
Beeson, W. M., 1965. Relative potencies of vitamin A and carotene for 
animals. Fed. Proc., 24:924-926. 
Belanger, L. F., and I. Clark, 1967. Alpharadiographic and histological 
observations on the skeletal effects of hypervitaminosis A and D in 
the rat. Anat. Rec., 158:443-447. 
Briggs, G. M., Jr., T. D. Luckey, C. A. Elvehjem and E. G. Hart, 1944. 
Effect of ascorbic acid on chick growth when added to purified 
rations. Proc. Soc. Exp. Biol. Med., 55:130-134. 
Chaudhuri, C. R., and I. B. Chatterjee, 1969. L-ascorbic acid synthesis 
in birds: phylogenetic trend. Science, 166:435-436. 
Chen, P. S., Jr., T. Y. Toribara and H. Warner, 1956. Microdetermination 
of phosphorus. Anal. Chem., 28:1756-1758. 
Couch, J. R., C. R. Creger and R. Chavez, 1971. Vitamin A requirement for 
growing turkeys. Br. Poult. Sci., 12:367-371. 
Creger, C. R., J. R. Couch and R. Chavez, 1971a. Conversion of B carotene 
to vitamin A in turkeys. Nutr. Rep. Int., 4:191-196. 
Creger, C. R., J. R. Couch and R. Chavez, 1971b. Alfalfa meal and an 
aquatic blend as a source of pro-vitamin A for the turkey poult. 
Nutr. Rep. Int., 4:197-205. 
Dietrich, L. S., W. J. Monson and C. A. Elvehjem, 1950. Effect of 
sulfasuxidine on the interrelation of folic acid, vitamin B22 and 
vitamin C. Proc. Soc. Exp. Biol. Med., 75:130-133. 
Dietrich, L. S., C. A. Nichol, W. J. Monson and C. A. Elvehjem, 1949. 
Observations on the interrelation of vitamin Bio, folic acid and 
vitamin C in the chick. J. Biol. Chem., 181:915-920. 
69 
Dorr, P. E., and C. F. Nockels, 1971. Effects of aging and dietary 
ascorbic acid on tissue ascorbic acid in the domestic hen. Poultry 
Sci., 50:1376-1382. 
El-Boushy, A. R., P. C. M. Simons and G. Wiertz, 1968. Structure and 
ultrastructure of the hen's egg shell as influenced by environmental 
temperature, humidity and vitamin C additions. Poultry Sci., 47: 
456-467. 
Flegal, C. J., P. J. Schaible and H. H. Hall, 1971. The relative 
biopotency of fermentation beta-carotene, crystalline beta-carotene 
and vitamin A for poultry. Poultry Sci., 50:349-358. 
Gallina, A. M., C. F. Helmbolt, H. I. Frier, S. W. Nielsen and H. D. Eaton, 
1970. Bone growth in the hypovitaminotic A calf. J. Nutr., 100:129-
142. 
Ghosh, N. C., I. Chatterjee and G. C. Chatterjee, 1967. Effects of 
vitamins A and D on the biosynthesis of L-ascorbic acid by rat-liver 
microsomes. Biochem, J., 97:247. 
Giroud, M. M. A., C. P. Leblond, R. Ratsimomanga and E. Gero, 1938. Le 
taux normal en acide ascorbique. Soc. de Chim. Bio., 20:1079-1087. 
Grollman, A. P., and A. L. Lehninger, 1957. Enzymic synthesis of L-ascorbic 
acid in different animal species. Arch. Biochem. Biophys., 69:458. 
Gurcay, R., R. V. Boucher and E. W. Callenback, 1950. Utilization of 
vitamin A by turkey poults. J. Nutr., 41:565-582. 
Hanninen, 0., R. Raunio and J. Mamiemi, 1971. Biosynthesis of L-ascorbic 
acid from myo-inositol. Carbohyd. Res., 16:343-351. 
Havivi, E., and G. Wolf, 1967. Vitamin A, sulfation and bone growth in 
the chick. J. Nutr., 92:467-473. 
Hayes, K. C., and R. J. Cousins, 1970. Vitamin A deficiency and bone 
growth. Calc. Tiss. Res., 6:120-132. 
Henshaw, W. R., and W. E. Lloyd, 1934. Vitamin A deficiency in turkeys. 
Hilgardia, 8:281. 
Herrick, R. B., and C. F. Nockels, 1969. Effects of a high level of 
dietary ascorbic acid on egg quality. Poultry Sci., 48:1518-1519. 
Heywang, B. W., and A. R. Kemmerer, 1955. The effects of procaine 
penicillin and ascorbic acid on egg weight and shell thickness during 
hot weather. Poultry Sci., 34:1032-1036. 
Howell, J. McC., and J. N. Thompson, 1967a. Lesions associated with the 
development of ataxia in vitamin A-deficient chicks. Br. J. Nutr., 
21:741-750. 
70 
Howell, J. McC., and J. N. Thompson, 1967b. Observations on the lesions 
in vitamin A-deficient adult fowls with particular references to 
changes in bone and central nervous system. Br. J. Exp. Path., 48: 
450-454. 
Hunt, J. R., and J. R. Aitken, 1962. Studies on the influence of 
ascorbic acid on shell quality. Poultry Sci., 41:219-226. 
Jacobson, B., and P. Havens, 1971. The effect of testerone on ascorbic 
acid synthesis in rooster comb. Biochem. Biophys. Acta, 237:490-493. 
Jensen, L. S., 1965. Vitamin A requirement of breeding turkeys. Poultry 
Sci., 44:1609-1610. 
Malathi, P., and J. Ganguly, 1964. Studies on metabolism of vitamin A. 7. 
lowered biosynthesis of ascorbic acid in vitamin A-deficient rats. 
Biochem. J. 92:521. 
Manual for Nutrition Surveys, 1963. Second Edition. Interdepartmental 
Committee on Nutrition for National Defense. U.S. Government Printing 
Office, Washington, D.C. 
March, B., and J. Biely, 1953. The effect of ascorbic acid on the growth 
rate of chicks. Poultry Sci., 32:768-774. 
Marusich, W., and J. C. Bauemfeind, 1963. The biological activity of 
B-carotene in poultry and rats. Poultry Sci., 42:949-957. 
Mayer, J., and W. A. Krehl, 1948. The relation of diet composition and 
vitamin C to vitamin A deficiency. J. Nutr., 35:523-537. 
Mellanby, E., 1950. A story of nutritional research. Williams and 
Wilkins Company, Baltimore, Md. 
Moore, L. A., and J. W. Cotter, 1945. The relationship between low 
carotene intake and urinary excretion of ascorbic acid in dairy 
cattle. J. Dairy Sci., 28:495-506. 
Nestor, K. E., S. P. Touchbum and M. Treiber, 1972. The influence of 
dietary ascorbic acid on blood ascorbic acid and egg production of 
turkeys. Poultry Sci., 51:1676-1680. 
Nockels, C. F., G. A. Lopez and R. W. Phillips, 1971. Influence of 
vitamins A anc C on corticosterone and carbohydrate metabolism in 
chickens. Fed. Proc. 30:584. 
Olsen, E. M. . J. D. Harvey, D. C. Hill and H. D. Brarion, 1959. 
Utilization and stability of commercial vitamin A supplements. 
Poultry Sci., 38:929-942. 
71 
Perkin-Elmer Corp., 1968. Revision of analytical methods for stomic 
absorption spectrophotometry. Perkin-Elmer Corp., Norwalk, Conn. 
Ramp, W. A., and P. A. Thornton, 1971. Ascorbic acid and the calcium 
metabolism of embryonic chick tibias. Proc. Soc. Exp. Bio. Med., 
137:273-276. 
Rogers, W. E., 1969. Reexamination of enzyme activities thought to show 
evidence of a coenzyme role for vitamin A. Am. J. Clin. Nutr., 22; 
1003-1013. 
Roy, R. N., and B. C. Guha, 1958. Species difference in regard to the 
biosynthesis of ascorbic acid. Nature, 182:319. 
Rumsey, G. L., 1969. Effects of stress upon egg shell quality in the 
laying hen. Proceedings, Cornell Nutrition Conference, 103-109. 
Satterfield, G. H., T. A. Bell, F. W. Cook and A. D. Homes, 1945. Effect 
of ascorbic acid injections on the amounts in the blood plasma of 
laying hens. Poultry Sci., 24:139-141. 
Scrimshaw, N. S., R. L. Goodland and F. B. Hutt, 1949. Variations in the 
ascorbic acid blood levels of hens. Poultry Sci., 28:45-51. 
Seawright, A. A., P. B. English and R. J. W. Gartner, 1970. Hypervitamin-
osis A of the cat. Adv. Vet. Sci. and Comp. Med., 14:1-23. 
Simmonds, R. A., 1965. Ascorbic acid levels in the blood of growing 
chickens. Poultry Sci., 44:308-310. 
Stoewsand, G. S., and M. L. Scott, 1961. The vitamin A requirement of 
breeding turkeys and their progeny. Poultry Sci., 40:1255-1262. 
Sullivan, T. W., and M. H, Gehle, 1962. Effect of ascorbic acid on the 
serum calcium level in laying hens fed graded levels of dietary 
calcium. Poultry Sci., 41:1016-1017. 
Taylor, T. G., K. M. L. Morris and J. Kirkley, 1968. Effects of dietary 
excesses of vitamin A and D on some constituents of the blood of 
chicks. Br. J. Nutr., 22:713-721. 
Thompson, J. N., and G. A. J. Pitt, 1960. Vitamin A acid and hyper-
vitaminosis A. Nature, 188:672-673. 
Thornton, P. A., 1960a. The influence of dietary protein level on the 
response of single comb white leghorns to supplementary ascorbic 
acid. Poultry Sci., 39:1072-1076. 
Thornton, P. A., 1960b. The effects of dietary calcium level on the 
efficiency of ascorbic acid in maintenance of egg shell thickness 
at increased environmental temperatures. Poultry Sci., 39:1401-1406. 
72 
Thornton, P. A., 1968. Bone salt mobilization effected by ascorbic acid. 
Proc. Soc. Exp. Bio. Med., 127:1096-1099. 
Thornton, P. A., 1970. Influence of exogenous ascorbic acid on calcium and 
phosphorus metabolism in the chick. J. Nutr., 100:1479-1486. 
Thornton, P. A., and R. E. Moreng, 1958. The effects of ascorbic acid on 
egg quality factors. Poultry Sci., 37:691-698. 
Thornton, P. A., and R. E. Moreng, 1959. Further evidence on the value of 
ascorbic acid for maintenance of shell quality in warm environmental 
temperature. Poultry Sci., 38:594-599. 
Thornton, P. A., and J. L. Omdahl, 1969. Further evidence of skeletal 
response to exogenous ascorbic acid. Proc. Soc. Exp. Bio. Med., 132: 
618-621. 
Thornton, P. A., D. Brownrigg and F. B. Mather, 1962. The influence of 
dietary ascorbic acid on the severity of beta-aminopropionitrite 
(BAPN) toxicity in turkeys. Poultry Sci., 41:1586-1589. 
Vaughan, J. N., 1970. The physiology of bone. Clarendon Press, Oxford. 
Webb, K. E., G. E. Mitchell, C. 0. Little and G. H. Schmitt, 1968. Polyuria 
in vitamin A-deficient sheep. J. Anim. Sci., 27:1657-1622. 
Wharton, F. D., L. D. Matterson, H. H. Scott and C. J. Bliss, 1949. The 
vitamin A requirements of growing turkeys. J. Nutr., 39:543-554. 
Wilgus, H. S., 1940. Experiments show turkey poults need four times as 
much vitamin A as do chicks. Colo. Farm Bull. ll:No. 1. 
Wolbach, S. B., 1954. Effects of vitamin A deficiency and hypervitaminosis 
A in animals. In The Vitamins, Vol. 1, p. 119. W. H. Sebrell, Jr. 
and R. S. Harris, eds. Academic Press, New York. 
Wolke, R. E., S. W. Nielsen and J. E. Rousseau, 1968. Bone lesions of 
hypervitaminosis A in the pig. Am. J. Vet. Res., 29:1009-1024. 
Zile, M., H. F. DeLuca and H. Ahrens, 1972. Vitamin A deficiency and 
urinary calcium excretion in rats. J. Nutr., 102:1255-1258. 
73 
ACKNOWLEDGEMENTS 
I wish to express my sincere appreciation to the following: 
To Dr. Stanley L. Balloun, for his advice and 
encouragement during the course of this study. 
To Drs. D. C. Beitz, R. C. Ewan, A. H. Trenkle and J. W. Young, 
for serving on my graduate committee. 
To Dr. D. F. Cox, for his help in the statistical analysis 
of the data. 
To my fellow graduate students for their assistance in the 
collection of these data. 
To my wife, Kathy, a special appreciation for her encouragement 
and understanding during the course of ny studies and for her efforts in 
typing the rough draft of this thesis. 
74 
APPENDIX 
75 
Table 36. Analyses of variance of body weight gain, feed consumption and 
feed efficiency - Experiment 1 
Source Mean squares 
of 
variation d.f. 
Weight 
eain 
Feed 
consumption 
Feed 
efficiency 
Block 2 367 10 0.0073 
Treatment 5 7965*** 9748*** 0.0311*** 
Cont. vs Inj. 
Cont. vs Diet. 
Diet, vs Inj. 
Cont. vs 3000 ppm 
(1) 
(1) 
(1) 
(1) 
19803*** 
337**. 
38557*** 
766 
8437*** 
9114* * 
44799%%% 
8664 
0.1456*** 
0.0480*** 
0.6942 
Error 10 108 436 0.0034 
^Significant at P<0.05. 
***Slgnlflcant at P<0.005. 
Table 37. Analyses of variance of plasma ascorbic acid concentration -
Experiment 1 
Source 
of 
variation d.f. 
Mean squares 
Plasma 
ÂÀ d.f. 
Mean squares 
Plasma® 
AA 
Block 2 1.484 2 3.530 
Treatment 5 169.415*** 4 181.920*** 
Cont. vs Inj. 
Cont. vs Diet. 
Diet, vs Inj. 
(1) 
(1) 
(1) 
3.375 
264.600*** 
194.400 
Linear on log(x)^ 
Lack of fit 
(1) 
(3) 
528.700*** 
66.300 
Linear on log(x+l)^ 
Lack of fit 
(1) 
(3) 
635.690*** 
30.730** 
Error 10 1.673 8 1.195 
***, Significant at P<0.005. 
Analysis of variance of control and dietary supplemental groups. 
X Is the dietary level of ascorbic acid. 
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Table 38. Analyses of variance of parameters of femur development -
Experiment 1 
Source Mean squares 
of 
variation d. f. 
Femur 
weight 
Femur 
length 
Femur weight 
Femur length 
Femur weight 
Body weight 
Block 2 523.03 1.12 0.30 0.0008 
Treatment 5 18527.61** 6.89** 5.13** 0.0019 
Cont. vs 
Cont. vs 
Diet, vs 
Inj. (1) 
Diet. (1) 
Inj. (1) 
** 
45414.00 
821.40 
88935.00 
13.50** 
1.35** 
33.75 
13.68** 
0.05 
24.04** 
Error 10 964.44 0.47 0.35 0.0031 
**Significant at P<0.01. 
Table 39. Analyses of variance of parameters of bone mineralization -
Experiment 1 
Source Mean squares 
of Ash Ca Phos Mg 
variation d.f. (%) (%) (%) Ca/P (%) 
Block 2 2.00 0.839 0.021 0.017 1083.7** 
Treatment 5 0.30 0.611 0.017 0.008 386.8 
Error 10 0.59 0.499 0.073 0.008 1.7 
Significant at P<0.01. 
Table 40. Analyses of variance for plasma calcium, magnesium and inorganic 
phosphorus - Experiment 1 
Source 
of Mean squares 
variation d. f. Calcium Phosphorus Magnesium 
Block 2 0.045 0.249 0.0261 
Xreatment b U.iiB 0.344 0.0063 
Error 10 0.261 0.262 0.0209 
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Table 41. Analyses of variance of body weight gain, feed consumption and 
feed efficiency in period 1 and period 2 - Experiment 2 
Source Mean squares 
of Weight gain Feed consumption Feed efficiency 
variation d.f. 1 2 1 2 1 2 
Block 2 
Ascorbic acid(AA) 3 
Linear(L) (1) 
Quad. (Q) (1) 
Cubic (C) (1) 
Vitamin A 2 
Linear (1) 
Quad. (1) 
AA X Vitamin A 6 
LL (1) 
LQ (1) 
QL (1) 
QQ (1) 
CL (1) 
CQ (1) 
Error 21 
26 240 522 
628 493 4230* 
1341 1336 8857 
367 93 949 
177 50 2884 
1269 1766 6895 
832* 1343 13556 
1706 2189 234 
805 860 2553 
0* 404 393 
2545 1014 7785 
1004 1226 118 
1069 323 6164 
32 1774 6201 
198 549 2888 
4"5 1225 974 
29904 0. 0028 0. 0481 
15174 0. 0046 0. 0248 
12236 0. 0073 0. 0038 
19462 0. 0000 0. 0424' 
13826 0. 0064 0. 0282 
19689 0. 0226* 0. 0095 
28667 0. 0289 0. 0182 
10710 0. 0162 0. 0007 
9317 0. 0090 0. 0104 
51 0. 0023 0.0016 
7728 0. 0005 0. 0017 
20886 0. 0098 0. 0118 
2964 0. 0132 0. 0123 
251 0. 0286* 0. 0133 
24402 0. 0046 0. 0233 
8724 0. 0053 0. ,0099 
*Significant at P<0.05. 
**Significant at P<0.01. 
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Table 42. Analyses of variance of femur weight and femur to body weight 
ratio - Experiment 2 
Source Mean squares 
of 
variation d. f. femur weight 
femur weight/ 
body weight 
Block 2 0.0228 0.0166 
Ascorbic acid 
Linear 
Quad. 
Cubic 
3 
(1) 
(1) 
(1) 
0.0135 
0.0369 
0.0005 
0.0031 
0.0370 
0.0117 
0.0367 
0.0625 
Vitamin A 
Linear 
Quad. 
2 
(1) 
(1) 
0.0449 
0.0145 
0.0752 
0.0489* 
0.0009 
0.0968 
AA X Vitamin A 
LL 
LQ 
QL 
QQ 
CL 
CQ 
6 
(1) 
(1) 
(1) 
(1) 
(1) 
(1) 
0.0375 
0.0016 
0.0900 
0.0586 
0.0295 
0.0379 
0.0005 
0.0186 
0.0114 
0.0042 
0.0408 
0.0091 
0.0705 
0.0013 
Error 21 0.0217 0.0128 
S^ignificant at P<0.05. 
Significant at P<0.01. 
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Table 43. Analyses of variance for parameters of femur mineralization -
Experiment 2 
Source 
of 
variation d. f. 
Mean squares 
% % % 
Ash Calcium Phosphorus 
Ca/P % 
ratio Magnesium 
Block 2.711 6.216 
** 
3.859 ** 0.0216 0.00215 
** 
Ascorbic acid 
Linear 
Quad. 
Cubic 
Vitamin A 
Linear 
Quad. 
(1) 
(1) 
(1) 
(1) 
(1) 
0.579 
1.672 
0.033 
0.034 
3.694, 
6.129 
1.258 
, ** 
1.767 
1.348 
0.720 
3.231 
3.363 
6.695' 
0.081 
** 
** 
0.131 
0.154 
0.239 
0.000 
0.329 
0.431 
0.226 
0.0371 
0.0026 
0.0536 
0.0551 
0.0216 
0.0324 
0.0108 
0.00025 
0.00045 
0.00016 
0.00012 
0.00171 
0.00245 
0.00097 
** 
** 
AA X Vitamin A 6 0.153 0.744 
LL (1) 0.052 2.818 
LQ (1) 0.009 0.261 
QL (1) 0.002 0.338 
QQ (1) 0.205 1.256 
CL (1) 0.131 0.124 
CQ (1) 0.529 0.119 
** 
0.238 
0.043 
0.234 
0.093 
0.304 
0.094 
0 .668  
0.0146 
0.0249 
0.0247 
0.0005 
0.0001 
0.0146 
0.0235 
0.00029 
0.00000 
0.00009 
0.00022 
0.00015 
0.00058 
0.00091 
Error 21 0.990 0.664 0.281 0.0177 0.00026 
** 
Significant at P<0.05. 
Significant at P<0.01. 
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Table 44. Analysis of variance of plasma ascorbic acid levels - Experiment 
2 
Source of variation d.f. Mean square 
Block 2 3.14 
Ascorbic acid (AA) 
Linear 
Quad. 
Cubic 
3 
(1) 
(1) 
(1) 
922.75*** 
2630.63*** 
108.77*** 
28.87** 
Vitamin A 2 1.57 
AA X Vitamin A 
LL 
6 
(1) 
Error (a) 10 1.42 
Period (P) 1 0.03 
Ascorbic acid x P 3 2.89 
Vitamin A x P 2 2.15 
Error (b) 40 1.73 
* 
Significant at P<0.05. 
** 
Significant at PcO.Ol. 
*** 
Significant at P<0.005. 
Table 45. Analyses of variance of plasma calcium and plasma inorganic 
phosphorus - Experiment 2 
Source of Mean squares 
variation d.f. Calcium Phosphorus 
Block 2 1.257 0.159 
Ascorbic acid (AA) 3 0.633 0.304 
Vitamin A 2 0.826 1.186 
AA x Vitamin A 6 0.500 0.603 
Error (a) 10 1.657 0.369 
Period (P) 
Ascorbic acid x F 
Vitamin A x P 
Error (b) 
1 
j 
2 
40 
42.440*** 
1.215 
0.151 
2.163 
16.960 
G. Goo 
0.418 
0.545 
***Significant at P<0.005. 
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Table 46. Analysis of variance for plasma magnesium - Experiment 2 
Source of 
variation d.f. Mean square 
Block 2 0.0703 
Ascorbic acid 3 0.0111 
Vitamin A 
Linear 
Quad. 
2 
(1) 
(1) 
0.0944* 
0.0843* 
0.1047* 
AA X Vitamin A 
LL 
LQ 
6 
(1) 
(1) 
0.0730* 
0.1759 
0.1845** 
Error (a) 10 0.0137 
Period (P) 1 2.1380*** 
Ascorbic acid x P 3 0.0495 
Vitamin A x P 2 0.0555 
Error (b) 40 0.0698 
*Significant at P<0.05. 
Significant at P<0.01. 
Significant at P<0.005. 
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Table 47. Analysis of variance of body weight gain - Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 
Block (B)/G 
1 
2 
51 
643 
Treatment (T)/G 1 5 804 
T/G 2 
Vitamin A^  
5 
(1) 
1052 
2599 
Error (a) 10 616 
Period (P) 
Week (W)/P 1 
W/P 2 
1 
1 
1 87216*** 
G X P 
G X W/P 1 
G X W/P 2 
1 
1 
1 
539 
9* 
1684 
T/G 1 X P 
T/G 1 X W/P 1 
T/G 1 X W/P 2 
W X AA 
5 
5 
5 
(1) 
383 
110* 
4092 
T/G 2 X P 
T/G 2 X W/P 1 
T/G 2 X W/P 2 
W X Vitamin A^  x AA 
5 
5 
5 
(1) 
407 
50 
793** 
2229 
Error (b) 36 411 
Significant at P<0.05. 
Significant at P<0.01. 
*** 
Significant at P<0.005. 
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Table 48. Analysis of variance of feed consumption - Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 1 472 
Block (B)/G 2 6371 
Treatment (T)/G 1 5 2669 
T/G 2 5 1391 
Error (a) 10 3929 
Period (P) 1 2776898' 
Week (W)/P 1 1 317075' 
W/P 2 1 529940' 
G X P 1 512 
G X W/P 1 1 24 
G X W/P 2 1 1849 
T/G 1 X P 5 2742 
P X Vitamin (1) 7713' 
T/G 1 X W/P 1 y 5 212 
T/G 1 X W/P 2 5 5803 
W X AA (1) 14377 
T/G 2 X P 5 1238 
T/G 2 X W/P 1 5 251 
T/G 2 X W/P 2 5 3111 
W X Vitamin Aq X AA (1) 7440 
Error (b) 36 1531 
*** 
*** 
*** 
** 
** 
Significant at P<0.05. 
** 
*** 
Significant at P<0.01. 
Significant at P<0.005. 
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Table 49. Analysis of variance of feed efficiency - Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 1 0.0016 
Block (B)/G 2 0.0750 
Treatment (T)/G 1 5 0.0302 
T/G 2 5 0.0164 
Error (a) 10 0.0263 
Period (P) 1 2.1061*** 
Week (W)/ P 1 1 0.3610 
W/P 2 1 0.3577 
G X P 1 0.0372 
G X W/P 1 1 0.0005** 
G X W/P 2 1 0.1139 
T/G 1 X P 5 0.0281 
T/G 1 X W/P 1 5 0.0087 
T/G 1 X W/P 2 5 0.0154 
T/G 2 X P 5 0.0141 
T/G 2 X W/P 1 5 0.0087 
T/G 2 X W/P 2 5 0.0203 
Error (b) 36 0.0153 
** 
Significant at P<0.05. 
*** 
Significant at P<0.005. 
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Table 50. Analysis of variance of femur weight - Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 1 0.002 
Block (B)/G 
Treatment (T)/G 1 
2 
5 
0.015** 
:::::: 
0:279** 
0.083** 
Vitamin Aj^  
T/G 2 
Vitamin A^  
Vitamin Ag 
(1) 
5 
(1) 
(1) 
Error (a) 10 0.011 
Period (P) 
Weeks (W)/P 1 
W/P 2 
1 
1 
1 
34.932** 
G X P 1 0.033 
G X W/P 1 1 0.010 
G X W/P 2 1 0.006 
T/G 1 X P 5 0.039. 
P X Vitamin A, 
T/G 1 X W/P 1 
(1) 0.086 
5 0.006 
T/G 1 X W/P 2 5 0.063 
0.306** W X Vitamin (1) 
T/G 2 X P 5 0.034 
P X Vitamin A. 
T/G 2 X W/P 1 
(1) 0.097* 
5 0.011 
T/G 2 X W/P 2 5 0.021 
Error (b) 36 0.019 
*Significant at P<0.05. 
Significant at P<0.01. 
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Table 51. Analysis of variance of femur length - Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 
Block (B)/G 
Treatment (T)/G 1 
Vitamin Aq 
T/G 2  ^
Vitamin Aj^  
Vitamin Aq 
1 
2 
5 
(1) 
5 
(1) 
(1) 
1009 
3582** 
598 
2009** 
Error (a) 10 117 
Period (P) 
Week (W)/P 1 
W/P 2 
1 
1 
1 
812544** 
103153 
103927 
G X P 
G X W/P 1 
G X W/P 2 
1 
1 
1 
133 
120 
11 
T/G 1 X P 
P X Vitamin A 
T/G 1 X W/P 1 
T/G 2 X W/P 2 
W X Vitamin A^  
5 
(1) 
5 
5 
(1) 
303 
3581 
105* 
813!* 
3400 
T/G 2 X P 
T/G 2 X W/P 1 
T/G 2 X W/P 2 
5 
5 
5 
59 
268 
261 
Error (b) 36 244 
Significant at P<0.05. 
** 
Significant at P<0.01. 
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Table 52. Analysis of variance of femur weight/body weight ratio -
Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 1 0.65 
Block (B)/G 2 12.41** 
Treatment (T) / G 1 5 11.51** 
Vitamin (1) 51.82 
T/G 2 5 8.49* 
Vitamin Al (1) 23.60* 
Vitamin Aq (1) 12.99 
Error (a) 10 2.16 
Period (P) 1 246.30** 
Week (W)/P 1 1 92.05** 
W/P 2 1 20.44** 
G X P 1 7.88 
G X W/P 1 1 0.72 
G X W/P 2 1 0.38 
T/G 1 X P 5 1.53* 
P X Vitamin A^  (1) 5.92 
T/G 1 X W/P 1 5 1.99 
W X Vitamin Aq (1) 5.88 
T/G 1 X W/P 2 5 1.00 
T/G 2 X P 5 1.18 
T/G 2 X W/P 1 5 3.55 
W X Vitamin Aq (1) 11.08 
T/G 2 X W/P 2 5 1.11 
Error (b) 36 1.20 
Significant at P<0.05. 
**Significant at P<0.01. 
* 
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Table 53. Analysis of variance of femur weight/femur length ratio -
Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 
Block (B)/G 
Treatment (T)/G 1 
Vitamin 
Vitamin 
T/G 2 
Vicamin 
Vitamin 
% 
Error (a) 
Period (P) 
Week (W)/P 1 
W/P 2 
1 
2 
5 
(1) 
(1) 
V) 
(1) 
10 
1 
1 
1 
0.0158 
0.0994 
0.2162** 
0.9113** 
0.1250* 
0.7128* 
0.1067 
0.0195 
60.2272 
6.3903" 
10.3716 
** 
** 
** 
G X P 
G X W/P 1 
G X W/P 2 
1 
1 
1 
0.0981 
0.0223 
0.0220 
T/G 1 X P 
P X Vitamin A-
T/G 1 X W/Pl 
T/G 1 X W/P 2 
W X Vitamin Aq 
T/G 2 X P 
P X Vitamin A_ 
T/G 2 X W/P 1 
T/G 2 X W/P 2 
(1) 
5 
5 
(1) 
(1) 
5 
5 
0.0683 
0.1842* 
0.0147 
0.0661 
0.3205 
0.0809 
0 .1985^  
0 .0202  
0.0380 
Error (b) 36 0.0330 
Significant at P<0.05. 
Significant at P<0.01. 
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Table 54. Analysis of variance of femur ash - Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 
Block (B)/G 
Treatment (T)/G 1 
Vitamin Aj^  
Vitamin Aq 
T/G 2  ^
Vitamin A^  
Vitamin Aq 
Error (a) 
Period (P) 
Week (W)/P 1 
W/P 2 
G X P 
G X W/P 1 
G X W/P 2 
T/G 1 X P 
P X Vitamin A^  
T/G 1 X W/P 1 
W X Vitamin A, 
T/G 1 X W/P 2 
T/G 2 X P 
T/G 2 X W/P 
W X Vitamin A_ 
T/G 2 X W/P 2 y 
Error (b) 
1 3.430* 
2 4.460* _ 
5 42.957** 
(1) 172.980*** 
(1) 41.818*** 
5 33.326*** 
(1) 154.880*** 
(1) 30.730*** 
10 0.625 
1 157.129*** 
1 98.957*** 
1 25.616*** 
1 0.007 
1 0.060 
1 0.154 
5 1.943 
(1) 6.994** 
5 1.703 
(1) 5.476* 
5 0.228 
5 0.852 
(1) 4.002 
5 1.876 
(1) 5.161* 
5 0.810 
36 0.668 
** 
*** 
Significant at P<0.05. 
Significant at P<0.01. 
Significant at P<0.005. 
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Table 55. Analysis of variance of percent calcium of femur - Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 
Block (B)/G 
Treatment (T)/G 
Vitamin 
T/G 2 
Vitamin 
Vitamin 
Vitamin 
4) 
Error (a) 
X AA 
Period (P) 
Week (W)/P 1 
W/P 2 
1 
2 
5 (1) 
(1) 
(1) 
10 
1 
1 
1 
0.000 
2.644, 
2.607, 
9.028 
6.657 
15.680 
13.024 
3.432^  
** 
** 
** 
** 
0.551 
5.767 
3.893" 
0.869 
** 
G X P 
G X W/P 1 
G X W/P 2 
1 
1 
1 
0.457 
1.255 
1.035 
T/G 1 X P 
T/G 1 X W/P 1 
T/G 2 X W/P 2 
5 
5 
5 
0.184 
0.477 
0.722 
T/G 2 X P 
T/G 2 X W/P 1 
T/G 2 X W/P 2 
5 
5 
5 
0.434 
0.733 
0.592 
Error (b) 36 0.592 
** 
Significant at P<0.05. 
t
Significant at P<0.01. 
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Table 56. Analysis of variance of percent phosphorus of femur - Experiment 
3 
Source of 
variation d.f. Mean square 
Group (G) 1 0.080 
Block (B)/G 2 0.423 
Treatment (T)/G 1 5 1.902 
Vitamin A^  (1) 5.780 
Vitamin A_ (1) 2.666 
T/G 2  ^ 5 1.313 
Vitamin (1) 4.440* 
Vitamin AQ (1) 1.793 
Error (a) 10 0.209 
Period (P) 1 1.285*^  
Week (W)/P 1 1 1.690 
W/P 2 1 0.497 
G X P 1 0.008 
G X W/P 1 1 0.258 
G X W/P 2 1 0.099 
it 
T/G 1 X P 5 0.267** 
P X Vitamin A^  (1) 0.871* 
P X Vitamin Aq (1) 0.375* 
T/G 1 X W/P 1  ^ 5 0.254* 
W X AA (1) 0.341* 
W X Vitamin A x C (1) 0.414 
T/G 1 X W/P 2 5 0.017 
T/G 2 X P 5 0.051 
T/G 2 X W/P 1 5 0.143 
T/G 2 X W/P 2 5 0.074 
Error (b) 36 0.073 
* 
Significant at P<0.05. 
** 
Significant at P<0.01. 
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Table 57. Analysis of variance of percent magnesium of femur - Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 
Block (B)/G 
Treatment (T)/G 1 
Vitamin A, 
T/G 2 
Vitamin 
Vitamin Aq 
1 
2 
5 
(1) 
5 
(1) 
(1) 
0.00008 
0.00148 
0.00903** 
0.03591** 
0.00587 
0.02268** 
0.00634 
Error (a) 10 0.00122 
Period (P) 
Week (W)/P 1 
W/P 2 
1 
1 
1 
0.05214** 
0.03127** 
0.01276 
G X P 
G X W/P 1 
G X W/P 2 
1 
1 
1 
0-00020 
0.00149 
0.00063 
T/G 1 X P 
P X Vitamin A. 
T/G 1 X W/P 1 
W X Vitamin Ay 
T/G 1 X W/P 2 
5 
(1) 
5 
(1) 
5 
0.00126* 
0.00510** 
0.00097. 
0.00235 
0.00063 
T/G 2 X P 
P X AA 
T/G 2 X W/P 1 
W X Vitamin A_ 
T/G 2 X W/P 2 y 
5 
(1) 
5 
(1) 
5 
0.00119* 
0.00375** 
0.00095* 
0.00327** 
0.00066 
Error (b) 36 0.00036 
Significant at P<0.05. 
Significant at P<0.01. 
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Table 58. Analysis of variance of the calcium/phosphorus ratio of femur -
Experiment 3 
Source of 
variation d. f. Mean square 
Group (G) 1 0.0017 
Block (B)/G 2 0.0609 
Treatment (T)/G 1 5 0.0676 
Vitamin A^  (1) 0.2285 
T/G 2 5 0.0352 
Error (a) 10 0.0253 
Period (P) 1 0.0908* 
Week (W)/P 1 1 0.0199 
W/P 2 1 0.0033 
G X P 1 0.0064 
G X W/P 1 1 0.0743 
G X W/P 2 1 0.0362 
T/G 1 X P 5 0.0199 
P X Vitamin & (1) 0.0902 
T/G 1 X W/P 1  ^ 5 0.0244 
T/G 1 X W/P 2 5 0.0084 
T/G 2 X P 5 0.0077 
T/G 2 X W/P 1 5 0.0114 
T/G 2 X W/P 2 5 0.0034 
Error (b) 36 0.0129 
* 
Significant at P<0.05. 
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Table 59. Analysis of variance of plasma ascorbic acid - Experiment 3 
Source of 
variation d.f. Mean square 
Group (G) 1 9 
Block (B)/G 2 7 
Treatment (T)/ G 1 5 498** 
AA (1) 2449** 
T/G 2 5 713 ** 
AA (1) 3365** 
Vitamin A^  (1) 100** 
W/P 2 
G X P 
G X W/P 1 
G X W/P 2 
T/G 1 X P 
P X Vitamin 
T/G 1 X W/P 1 
W X Vitamin 
W X Vitamin 
T/G 1 X W/P 2 
W X Vitamin 
W X Vitamin 
T/G 2 X P 
T/G 2 X W/P 1 
T/T 2 X W/P 2 
W X AA 
W X Vitamin 
** Vitamin A^  x AA (1) 91 
Error (a) 10 7 
Period (P) 1 548** 
Week (W)/P 1 1 30** 
1 165** 
1 4 
1 0 
1 15* 
5 7 
At X AA (1) 24** 
5 11* 
V (1) 14* 
5 s; 
* 
(1) 14* 
AL X AA (1) 21 
5 3 
5 9* 
5 20** 
(1) 24** 
A. (1) 38** 
Error (b) 36 
Significant at P<0.05. 
**Significant at P<0.01. 
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Table 60. Analyses of variance of plasma calcium and magnesium - Experiment 
3 
Source of Mean squares 
variation d.f. Calcium Magnesium 
Group (G) 1 0.62 0.650* 
Block (B)/G 2 0.77 0.176 
Treatment (T)/G 1 5 1.06 0.114 
T/G 2 5 0.81 0.070 
Error (a) 10 2.53 0.096 
Period (P) 1 3.75. 0.194** 
Week (W)P 1 1 14.43 0.792** 
W/P 2 1 91.96** 4.419 
G X P 1 2.86 0.011 
G X W/P 1 1 3.67 0.016 
G X W/P 2 1 8.69 0.165 
T/G 1 X P 5 1.82 0.041 
T/G 1 X W/P 1 5 3.29 0.037 
T/G 1 X W/P 2 5 1.63 0.032 
T/G 2 X P 5 1.37 0.016 
T/G 2 X WPP 1 5 0.78 0.017 
T/G 2 X W/P 2 5 2.05 0.069 
Error (b) 36 2.91 0.092 
*Significant at P<0.05. 
** 
Significant at P<0.01. 
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Table 61. Analysis of variance of plasma inorganic phosphorus - Experiment 
3 
Source of 
variation d.f. Mean square 
Group (G) 
Block (B)/G 
Treatment (T)/G 1 
Vitamin A^  
Vitamin AQ 
T/G 2 
Vitamin A^  
1 
2 
5 
(1) 
(1) 
5 
(1) 
0.63 
4.03 
8.12** 
29.06* 
7.65* 
5-67** 
19.38 
Error (a) 10 1.51 
Period (P) 
Week (W)/P 1 
W/P 2 
1 
1 
1 
33-8411 
30.64 
15.44 
G X P 
G X W/P 1 
G X W/P 2 
1 
1 
1 
0.15 
0.00 
1.40 
T/G 1 X P 
T/G 1 X W/P 1 
W X AA 
T/G 1 X W/P 2 
W X Vitamin AQ x AA 
5 
5 
(1) 
5 
(1) 
0.71 
1.09^  
3.68 
3.73** 
17.65** 
T/G 2 X P 
T/G 2 X W/P 1 
T/G 2 X W/P 2 
W X Vitamin A^  x AA 
5 
5 
5 
(1) 
0.99 
0.56^  
2.11 
5.18* 
Error (b) 36 0.81 
*Significant at P<0.05. 
Significant at P<0.01. 
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Table 62. Analysis of variance for body weight gains - Experiment 4 
Source of 
variation d. f. Mean square 
Block 1 165415*** 
Vitamin A (VA) 2 76745* 
Ascorbic acid (AA) 1 28005 
VA X AA 2 8628 
Sex (S) 1 8426933*** 
VA X S 2 66275* 
AA X S 1 14012 
VA X AA X S 2 148 
Error (a) 11 11715 
Age (A) *** 4 38331337 
VA X A 8 37313 
AA X A 4 9078 
VA X AA X A 8 13685 
S X A 4 1837792 
VA X S X A 8 29625 
AA X S X A 4 7064 
VA X AA X S X A 8 4427 
Error (b) 48 16853 
Significant at P<0.05. 
Significant at P<0.005. 
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Table 63. Analyses of variance for feed consumption and feed efficiency -
Experiment 4 
Source of Mean squares 
variation d.f. Feed consumption Feed efficiency 
Block 
Vitamin A (VA) 
Ascorbic acid (AA) 
VA X AA 
1 
2 
1 
2 
3020113 
275058 
1858454 
1193288 
0.00315 
0.02713 
0.00874 
0.23900 
Sex (S) 
VA X S 
AA X S 
VA X AA X S 
1 
2 
1 
2 
81004561*** 
5621773 
761922 
1834366 
0.25475 
0.13499 
0.02414 
0.08889 
Error (a) 11 1899339 0.12437 
Age (A) 
VA X A 
AA X A 
VA X AA X A 
S X A 
VA X S X A 
AA X S X A 
VA X AA X S X A 
4 
8 
4 
8 
4 
8 
4 
8 
*** 
843848390 
976534** 
0 
431456 
21063724*** 
314132 
389854 
149696 
39.02235*** 
0.03054 
0.07069 
0.01125 
0.01499 
0.01058 
Error (b) 45 297422 0.02910 
**Significant at P<0.01. 
***Significant at P<0.005. 
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Table 64. Analyses of variance for parameters of femur development -
Experiment 4 
Source 
of Femur Femur Femur weight/ Femur weight/ 
variation d. f. weight length femur length body weight 
Block 1 1.693 0.122 174.0* 0.315*** 
Vitamin A (VA) 
Ascorbic acid (AA) 
2 
1 
8.629^; 
3.893 
1.648:** 
0.337 
313.9*** 
213.4 
0.028* 
0.034 
VA X AA 2 0.951 0.114 70.5 0.003 
Sex (S) 1 73.681*** 7.792*** 3488.4** 0.325*** 
0.039. VA X S 2 2.970* 0.139 137.7 
AA X S 1 0.824 0.062 35.0 0.022 
VA X AA X S 2 0.179 0.039 6.6 0.000 
Error (a) 11 0.389 0.048 20.7 0.003 
Age (A) 1 388.684*** 
*** 
49.857 19829.1*** 0.018 
VA X A 2 2.760 0.172 84.5 0.013 
AA X A 1 1.573 0.066 69.1 0.005 
VA X AA X A 2 0.090 
645^5*** 
0.006 
S X A 1 0.429 0.096 
VA X S X A 2 2.972 0.108 156.7 0.006 
AA X S X A 1 0.596 0.019 28.8 0.023 
VA X AA X S X A 2 0.089 0.001 6.0 0.002 
Error (b) 12 0.642 0.161 30.1 0.025 
Significant at P<0.05. 
Significant at P<0.01. 
Significant at P<0.005. 
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Table 65. Analyses of variance of calcium, phosphorus and calcium/ 
phosphorus ratio of femur - E%pe.rlinent 4 
Source of 
variation d.f. 
Wean squares 
Calcium Phosphorus Ca/P ratio 
Block 1 0.644 0.488 0.0295 
Vitamin A (VA) 2 1.347 2.948 0.1609* 
Ascorbic acid (AA) 1 0.919 0.001 0.0130 
VA X AA 2 0.079 0.089 0.0011 
Sex (S) 1 0.832 0.141 0.0002 
VA X S 2 0.010 0.905 0.0245 
AA X S 1 1.038 0.357 0.0000 
VA X AA X S 2 0.154 0.393 0.0218 
Error (a) 11 0,740 0.546 0.0304 
Age (A) 1 2.448* 0.677 0.0001 
VA X A 2 0.509 0.079 0.0032 
AA X A 1 0.696 0.003 0.0073 
VA X AA X A 2 0.148 0.069 0.0049 
S X A 1 2.245 0.049 0.0124 
VA X S X A 2 0.056 0.103 0.0029 
AA X S X A 1 0.012 0.101 0.0015 
VA X AA X S X A 2 0.428 0.016 0.0015 
Error (b) 12 0.474 0.242 0.0080 
Significant at P<0.05. 
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Table 66. Analyses, of variance of ash and magnesium of femurs - Experiment 
4 
Source of Mean squares 
variation d. f. Ash Magnesium 
Block 1 10.416** 0.00421 
Vitamin A (VA) 2 5.227** 0.00237 
Ascorbic acid (AA) 1 2.530 0.00421 
VA X AA 2 0.638 0.00567 
Sex (S) 1 0.025 0.00035 
VA X S 2 0.644 0.00458 
AA X S 1 0.008 0.00025 
VA X AA X S 2 0.271 0.00040 
Error (a) 11 0.692 0.00473 
Age (A) 
*** 
1 24.739 0.00317 
VA X A 2 1.156 0.00162 
AA X A 1 3.899 0.00110 
VA X AA X A 2 1.121 0.00040 
S X A 1 0.368 0.00227 
VA X S X A 2 0.594 0.00049 
AA X S X A 1 1.038 0.00075 
VA X AA X S X A 2 1.201 0.00127 
Error (b) 12 1.240 0.00141 
Significant at P<0.01. 
ifc 3^   
Significant at P<0.005. 
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Table 67. Analyses of variance for plasma ascorbic acid, plasma calcium, 
plasma inorganic phosphorus and plasma magnesium - Experiment 4 
Source of Mean squares 
variation d.f. Ascorbic acid Calcium Phosphorus Magnesium 
Block 1 248* 0.167 24.38 0.0004 
Vitamin A (VA) 
Ascorbic acid (AA) 
VA X AA 
2 
1 
2 5 
2.267 
1.261 
2.111 
1.25 
2.45 
1.13 
0.0093 
0.0385 
0.0146 
Error (a) 5 23 1.708 5.89 0.0201 
Sex (S) 
VA X S 
AA X S 
VA X AA X S 
1 
2 
1 
2 
5 
6 
2 
3 
0.057^  
3.755 
0.028^  
1.974 
4.22 
1.03 
1.54 
2.44 
0.0025 
0.0569 
0.0199 
0.0089 
Error (b) 6 29 0.351 4.29 0.0151 
Week (W) 
VA X W 
AA X W 
VA X AA X W 
S X W 
VA X S X W 
AA X S X W 
VA X AA X S X W 
2 
4 
2 
4 
2 
4 
2 
4 
1531** 
16 
90 
12 
9 
29 
16 
8 
6.061 
0.675 
1.357 
1.236 
2.488 
1.569 
0.774 
0.490 
31.36* 
3.73 
0.43 
3.43 
24.27 
3.73 
7.11 
2.95 
0.0466 
0.0072 
0.0235 
0.0171 
0.0353 
0.0212 
0.0198 
0.0246 
Error (c) 24 72 2.662 5.37 0.0436 
Significant at P<0.05. 
** 
Significant at P<0.01. 
Significant at P<0.005. 
